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EpidEmiological TransiTion: THE siTUaTion in 
indonEsia
There has been an alarming increase in the worldwide burden of type 2 diabetes 
(T2D) [1], especially in low and middle-income countries (LMIC),[2] including 
Indonesia. As the fourth world’s most populous country, Indonesia is currently 
undergoing an epidemiological transition. In 2014, 77% of total mortality was 
estimated to be attributed to non-communicable diseases (NCD), of which diabetes 
was the third highest after cardiovascular disease (CVD) and cancer.[3] This number 
considerably increased from the previous report in 2010, of which 63% of all deaths 
were attributed to NCDs. It is important to note, that whereas the percentage of 
mortality attributed to CVD and cancer were relatively constant, the diabetes-
attributable death has doubled from 3% to 6%[3]. However, a marked geographical 
variation in disease patterns exists, which is exemplified by the high prevalence of 
infectious diseases in rural area, but of NCDs, including T2D, in urban areas.
In 2015, the International Diabetes Federation reported that, whereas, 6.5% 
of Indonesian adults have diabetes, 17.9% of them also have impaired glucose 
tolerance (IGT), which is associated with a higher risk to develop T2D.[1] These 
numbers have substantially increased from previous study in 2007 which reported 
that the prevalence of diabetes and IGT was 5.7% and 10.2%, respectively.[4] 
Epidemiological studies of diabetes have indicated that the prevalence in Jakarta, 
the capital city of Indonesia, rose from 1.7% in 1982 to 5.7% in 1993, and then more 
than doubled to 12.8% in 2001.[5] A study in Ujung Pandang, a metropolitan center 
on Sulawesi island, also showed similar results.[5] Despite the paucity of data from 
rural areas, a study in Ende, Flores island, a rural area of Indonesia, found a much 
lower prevalence of T2D of 1.56%.[6] The results of these epidemiological studies 
in urban and rural area of Indonesia, which are in line with studies elsewhere on the 
association between rural-to-urban migration and increased risk of T2D and other 
CVD risk factors,[7-11] indicates the importance of expanding studies to outside of 
urban centers. Collecting information from rural areas, not only would help prepare 
the health system for emerging diseases but it will also enable the identification of 
important risk factors for CVD and therefore guiding interventions. One potentially 
important aspect of rural areas, where 40% of the Indonesian population lives,[3] 
is the possible effect helminth infections might have on glucose metabolism.[12]
Helminth infections affect approximately 1.4 billion people worldwide, of which 

















example soil-transmitted helminths (STH), which  despite a decrease in overall 
national prevalence from 47.2% to 24.6%,[13] are still very prevalent in most rural 
area of Indonesia,[15-17] and in some villages more than 80% of the population 
are infected with these parasites[15, 17], which in part is due to the tropical and 
moist climate.[18] Poor sanitation infrastructure and hygiene practises, as well 
as lack of adequate clean water resources, might also contribute.[19] 
inVErsE associaTion BET WEEn HEl minTH 
infEcTions and T2d
Worldwide, there is little overlap between the prevalence of soil-transmitted 
helminths and T2D (figure 1), which is supported by a number of epidemiological 
studies in different populations reporting an inverse association between helminths 
and metabolic diseases.[20-24]. Interestingly, these studies consistently reported 
an inverse association between previous [22, 23] or current [20, 21] helminth 
infections and metabolic diseases, namely metabolic syndrome prevalence [22, 
23], T2D prevalence [21, 23] and Insulin Resistance (IR), as assessed by homeostatic 
model assessment (HOMA)-IR[20]. 
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Figure 1. Worldwide prevalence of soil-transmitted helminths (STH) and diabetes. STH prevalence is defined 
as the estimated proportion of children (1-14 years of age) requiring preventive chemotherapy for STH per 
country,[14] of which in this figure, proportion of lower than 1/3 is considered low. The prevalence of diabetes 
in adults (20-79 years of age) per country,[1] of which in this figure prevalence of lower than 7% is considered 
as low). 
 
The association between previous helminth infections and metabolic diseases has been reported in China. 
Chen et al. used self-reported disease and medication history, cross-referenced with local government registry 
data, as a method to diagnose previous schistosome infections (PSI)[23]. The prevalence of both T2D and 
metabolic syndrome was significantly lower in the group with PSI compared to the non-PSI group (14.9% vs 
25.4%, P<0.0001; 14.0% vs 35.0%, P<0.0001, respectively). In addition, PSI was associated with lower levels of 
body mass index (BMI), HOMA-IR, plasma fasting blood glucose, postprandial blood glucose, and glycated 
haemoglobin A1c (HbA1c)[23]. A different method of PSI diagnosis was used by Shen et al., because 
schistosome-associated liver pathology can be present for years, therefore ultrasonography was performed to 
detect chronic schistosomal liver disease [22]. PSI was significantly associated with a lower prevalence of 
metabolic syndrome (18.28% in PSI group vs 34.01% in control group) and its components, including central 
obesity, hypertension, low high-density lipoprotein cholesterol (HDL-C), hypertriglyceridemia, and 
hyperglycaemia. [22] 
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The association between previous helminth infections and metabolic diseases has 
been reported in China. Chen et al. used self-reported disease and medication 
history, cross-referenced with local government registry data, as a method to 
diagnose previous schistosome infections (PSI)[23]. The prevalence of both T2D and 
metabolic syndrome was significantly lower in the group with PSI compared to the 
non-PSI group (14.9% vs 25.4%, P<0.0001; 14.0% vs 35.0%, P<0.0001, respectively). 
In addition, PSI was associated with lower levels of body mass index (BMI), 
HOMA-IR, plasma fasting blood glucose, postprandial blood glucose, and glycated 
haemoglobin A1c (HbA1c)[23]. A different method of PSI diagnosis was used by Shen 
et al., because schistosome-associated liver pathology can be present for years, 
therefore ultrasonography was performed to detect chronic schistosomal liver 
disease [22]. PSI was significantly associated with a lower prevalence of metabolic 
syndrome (18.28% in PSI group vs 34.01% in control group) and its components, 
including central obesity, hypertension, low high-density lipoprotein cholesterol 
(HDL-C), hypertriglyceridemia, and hyperglycaemia. [22]
The inverse association between current helminth infections and metabolic 
diseases was first reported in Chennai, India. Aravindhan et al. reported a 
significantly lower prevalence of lymphatic filariasis among diabetic subjects 
compared to pre-diabetic and non-diabetic subjects [24]. Furthermore, Hays 
et al. found that among 259 Australian Aboriginal adults, participants with a 
chronic S. stercoralis infection, as defined by serological testing, were 61% less 
likely to be diagnosed with T2D compared to those who were uninfected, after 
adjustment for age, blood pressure, triglycerides and BMI [21]. Furthermore, it 
was shown by a study in rural area of Indonesia that subjects with a current STH 
infection had a lower BMI and lower levels of HOMA-IR, indicating that infected 
subjects were more insulin sensitive compared to uninfected subjects [20]. A 
significant negative association was found between the number of helminth 
species a subject was infected with and HOMA-IR, even after adjustment for age, 
sex and BMI [20]. 
A recent meta-analysis showed that individuals with a previous or current helminth 
infection were 50% less likely to have an outcome of metabolic dysfunction 
(hyperglycaemia, T2D, metabolic syndrome or insulin resistance) compared 
to those uninfected (OR 0.50; 95% CI 0.38-0.66) [12]. However, cross-sectional 
studies provide no information on the causal relationship between helminths and 

















mEcHanism BEHind THE inVErsE associaTion 
BET WEEn HEl minTHs and T2d
adiposity and adipose Tissue inflammation
Insulin resistance, a decrease in insulin-stimulated glucose uptake, is a hallmark of 
T2D leading to hyperglycaemia. Whereas increased adiposity has been associated 
with an increased risk of developing IR and T2D[25], helminth infection has been 
commonly associated with a poor nutritional status and reduced adiposity,[20, 22, 
23] suggesting that helminth-associated lower adiposity may contribute to the 
observed lower IR.[20] However, despite the abundance of evidence on the role of 
human adipose tissue on IR, which will be summarized below, no data are available 
on the effect of helminth infections on human adipose tissue.
Obesity-induced chronic low-grade inflammation seems to be a key feature in the 
development of IR, hence T2D [26-29]. Initiation of inflammation in obesity involves 
inflammation of visceral adipose tissue (VAT), and the release of free fatty acids 
(FFA) as well as liver inflammation (called non-alcoholic steatohepatitis (NASH)), 
which then promote systemic inflammation, reflected in increased levels of pro-
inflammatory cytokines,[26] such as TNF-α,[30, 31] that  lead to an impairment in 
insulin signalling.[26] This will  thereby affect glucose levels by leading to a reduced 
glucose uptake in skeletal muscles, increased hepatic gluconeogenesis, and an 
increase in circulating free fatty acids.[26]
Adipose tissue inflammation plays a prominent role in the development of 
obesity-induced inflammation [27], which is characterized by the accumulation of 
inflammatory cells in obese adipose tissue creating a pro-inflammatory milieu [32]. 
A number of studies have shown that there is a phenotypic switch [33-35] from anti-
inflammatory alternatively activated macrophages (AAM or M2) in adipose tissue, 
which are activated by IL-4 and IL3 and express anti-inflammatory IL-10 [32, 36], 
towards pro-inflammatory classically activated macrophages (CAM or M1), which 
secrete various pro-inflammatory mediators (TNF-α, IL-6, IL-1β, IL-12, IL-23) [32, 36]. 
This phenotypic switch is positively correlated with IR.[33-35] 
In addition, an imbalance between pro- and anti-inflammatory adipokines may also 
contribute to the development of IR [37]. Leptin, a pro-inflammatory adipokine 
[37], can increase and suppress the production of circulating Th1 and Th2 type 
cytokines, respectively [38]. Other pro-inflammatory adipokines, such as resistin, 

















protein (ANGPTL) 2, CC-chemokine ligand (CCL) 2, and CXC-chemokine ligand 
(CXCL) 5 have been reported to be upregulated in an obese state [37]. Adiponectin, 
an anti-inflammatory adipokine [39, 40], can stimulate the production of IL-10 by 
macrophages [41]. Recently, another anti-inflammatory adipokine, Sfrp5, was 
reported to have beneficial metabolic effects [39].
Aside from the adipose tissue, inflammation in other tissues, such as liver, skeletal 
muscle and the pancreas, might also contribute to the development of obesity-
induced inflammation and therefore the development of IR. In obesity, the 
activation state, but not the number of Kupffer cells (KC), in the liver changes[42, 
43] promoting the expression of inflammatory genes,[42] as well as the production 
of inflammatory mediators which leads to an increased IR in the liver.[43] Liver 
inflammation might also be initiated by the abdominal adipose tissue-associated 
increased secretion of pro-inflammatory cytokines into the portal circulation.
[27] In contrast, skeletal muscles may not be the site where inflammation is 
initiated, but the target of inflammation-induced IR.[27] An increased expression 
of inflammatory markers within skeletal muscle was only reported among obese 
people with T2D, but not among obese people without T2D.[44] In the pancreatic 
islets of diabetics, increased levels of the pro-inflammatory cytokine IL-1β have 
been found,[45] which is a master regulator of islet cell inflammation in T2D.
[46] This pancreatic islet inflammation is a key step in the development of T2D, 
as the failure of beta cells to compensate IR will lead to the development of 
hyperglycaemia and T2D.[47]
immunomodulatory Effects of helminths
Helminth has been shown to be a potent natural inducer of type 2 and regulatory 
responses.[48-51] As chronic low grade inflammation plays a key role in the 
development of IR and T2D,[29] helminth-associated immune responses may 
therefore dampen systemic inflammation, hence increasing insulin sensitivity.
[52-54] Despite the possible main role of adiposity in mediating the helminths-
associated protective effects in human, it has been reported that even after 
adjustment for adiposity, the association between helminth infections and lower 
IR is not completely attenuated [20], suggesting that other pathways, such as 
helminth-associated immunomodulatory effects, may be involved. 
A number of experimental studies in mouse models have provided evidence for 
the beneficial effects of helminths and helminth-derived molecules on metabolic 

















could explain the link between helminths and T2D. Helminths influence metabolic 
homeostasis,[61-63] at least partly, by changing the immune cell composition in 
the adipose tissue. Whereas obesity-induced low-grade chronic inflammation is 
characterized by the accumulation of CD8+ T cells, CD4+ Th1 cells, CAMs, B cells 
and mast cells in the adipose tissue (AT), chronic helminth infections or helminth-
derived molecules induce increased numbers of CD4+ Th2 cells, eosinophils, 
AAMs, Tregs and ILC2s, dampening the inflammation and improving glucose 
tolerance. 
Although there is very little human data available that could explain the mechanism 
by which helminths may protect against T2D, it can be speculated that helminths 
suppress chronic inflammation associated with T2D by modulating the immune 
response. Recent population-based study has shown that community deworming 
program alleviates helminth-associated immune hyporesponsiveness,[64] 
however, the question whether this would lead to the development of inflammatory 
disorders, including T2D, in the future, remains unanswered. 
Taken together, there is evidence that suggests living a more traditional lifestyle 
in a rural environment might confer a protective effect against the development 
of NCDs, including T2D. With the rapid pace of socioeconomic development and 
increased rate of urbanization, these relatively protective lifestyle and environment 
will progressively subside. In urban areas or urbanized communities, changes 
toward a more sedentary lifestyle and increased consumption of energy-dense 
food, will lead to a positive energy balance and increased adiposity, contributing to 
the increased burden of T2D.[65] It is also hypothesized that improved hygiene and 
sanitation in parallel with the current deworming programs, leading to a decreased 
exposure to helminth infections, which have been shown to have a protective 
metabolic effect,[12, 20-23] might also contribute to the increasing prevalence 
of T2D.[52-54] The proposed association between epidemiological transition, 
urbanization, insulin resistance, and helminth infections are schematically 

























































































































































































































































































































































































































































































































































































































































scopE and aims of THE THEsis
The main objective of this thesis is to improve understanding of the role of 
helminth infections in the development of IR, hence T2D, in the light of increasing 
urbanization in Indonesia. We aimed to unravel the causal effect of helminth 
infections on human metabolic homeostasis by assessing how anthelmintic 
treatment (deworming) could affect IR and other metabolic parameters. Our large 
scale cluster randomized controlled trial (RCT) was performed in a rural area of 
Indonesia, which is an area endemic for STH, and has been previously reported 
to have a low prevalence of IR and T2D. We also assessed the role of adiposity 
and adipokines in mediating the effect of helminths on IR. Next, we also aimed 
to assess the different metabolic profile between populations living in rural and 
urban area, and to study the relative protective effect of rural environment on the 
development of IR by performing a short-term high-fat diet intervention study.
The first part of this thesis addresses the following question: 
What is the effect of anthelmintic treatment (deworming) on host metabolic 
homeostasis?
chapter 2 describes the design of an RCT to answer the question whether 
anthelmintic treatment will affect host metabolic homeostasis by performing a 
household-clustered randomized double-blinded placebo-controlled anthelmintic 
trial in an area endemic for STH in Indonesia. 
chapter 3 describes the outcomes of this RCT on STH prevalence, Th2 responses, 
adiposity, and IR
chapter 4 describes the outcome of this RCT on adipokines and how this mediates 
the changes in IR
The second part of this thesis we focus on the following question:
What are the differences in metabolic profiles between populations in rural 
and urban areas?
chapter 5 describes the different metabolic profile of subjects with the same 
genetic background living in rural and urban areas. It also describes their responses 
to a short-term high fat diet intervention.
chapter 6 summarizes our findings and provide directions for future research to 
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Background: Insulin resistance is a strong predictor of the development of 
type 2 diabetes mellitus. Chronic helminth infections might protect against 
insulin resistance via a caloric restriction state and indirectly via T-helper-2 
polarization of the immune system. Therefore, the elimination of helminths 
might remove this beneficial effect on insulin resistance.
methods/design: To determine whether soil-transmitted helminth 
infections are associated with a better whole-body insulin sensitivity 
and whether this protection is reversible by anthelmintic treatment, a 
household-based cluster-randomized, double blind, placebo-controlled 
trial was conducted in the area of Nangapanda on Flores Island, Indonesia, an 
area endemic for soil-transmitted helminth infections. The trial incorporates 
three monthly treatment with albendazole or matching placebo for one 
year, whereby each treatment round consists of three consecutive days of 
supervised drug intake. The presence of soil-transmitted helminths will be 
evaluated in faeces using microscopy and/or PCR. The primary outcome 
of the study will be changes in insulin resistance as assessed by HOMA-IR, 
while the secondary outcomes will be changes in body mass index, waist 
circumference, fasting plasma glucose, 2h-glucose levels after oral glucose 
tolerance test, HbA1c, serum lipid levels, immune system, and efficacy of 
anthelmintic treatment.
discussion: The study will provide data on the effect of helminth infections 
on insulin resistance. It will assess the relationship between helminth 
infection status and immune responses as well as metabolic parameters, 
allowing the establishment of a link between inflammation and whole-body 
metabolic homeostasis. In addition, it will give information on anthelmintic 
treatment efficacy and effectiveness. 
Trial registration: This study has been approved by the ethical committee 
of Faculty of Medicine Universitas Indonesia (ref: 549/H2.F1/ETIK/2013), and 
has been filed by the ethics committee of Leiden University Medical Center, 
clinical trial number: ISRCTN75636394. The study is reported in accordance 
with the CONSORT guidelines for cluster-randomised trials.

















































The number of people with diabetes mellitus is increasing worldwide [1-3]. At 
present, 8.3% of adults (382 million people) have diabetes mellitus [4] and Asia is a 
major site of this rapidly emerging epidemic [5]. In many Asian countries, including 
Indonesia, rapid socio-economic development has led to a shift in infrastructure, 
technology and introduction of Western style diets, which promotes overnutrition 
and sedentary lifestyles [5-8]. These changes have already led to an increasing 
prevalence of diabetes mellitus in Indonesia [9-12].
A strong predictor for the development of type 2 diabetes mellitus (DM2) is insulin 
resistance [13,14], which is caused by complex disturbances in multiple biological 
systems. There is now abundant evidence that inflammation [15] plays a role in the 
development of DM2, in addition to the more established relationship between an 
altered energy balance resulting from excess consumption of high-energy foods 
and/or decreased physical activity. In DM2 subjects, chronic low-grade inflammation 
is a common feature [15], which results, at least in part, from the activation of 
inflammatory pathways by fatty acids in multiple organs [16-18]. However, the 
fundamental molecular mechanisms are still incompletely understood [19]. 
In developing countries, infectious pressure might be one particular modifier of insulin 
resistance. Helminth infections, which are still endemic in many low to middle income 
countries, may therefore affect whole-body and tissue-specific insulin sensitivity 
owing to their immunomodulatory properties.[20] Previous studies have shown that 
helminth infections can adopt an immune evasion strategy by inducing regulatory 
T cells. [21-26] Hereby helminth infections may decrease systemic inflammation and 
subsequently the development of inflammatory diseases, including DM2 [27-30]. 
Studies examining the relationship between helminth infections and DM2 in both 
humans [31,32,32] and rodents [33,34] support this hypothesis. Recent landmark 
studies in animal studies have also established important links between metabolism 
and the immune response. At a molecular level, mTOR, a serine/threonine protein 
kinase located downstream of insulin signalling, plays an essential role in immune 
cell energy metabolism and function [35,36]. Furthermore, it has been shown that 
STAT6 signalling downstream of IL-4, as well as Th2 responses induced by helminths, 
improve glucose metabolism and insulin signalling [33,37]. Intriguingly, in humans, 
immune intervention with IL-1 receptor antagonist (Anakinra) has also been shown 















































Helminths are also known to reduce energy intake and thereby change the energy 
balance [39], which may be beneficial in terms of insulin resistance [39,40]. Helminths 
may therefore both directly improve insulin sensitivity via a caloric restriction 
state and indirectly via Th2 activation. It appears, the immune system, which has 
evolved with helminths [41] and under conditions of low energy intake, seems to 
be out of balance in situations of nutritional overload and decreasing exposure to 
parasites [23,42]. In line with the proposed beneficial effects of helminth infections 
on glucose metabolism, our previous unpublished cross sectional study in Flores 
Island, Indonesia, has shown that subjects infected with intestinal helminths have a 
significantly lower insulin resistance as expressed by HOMA-IR.
Although aforementioned studies strongly suggest that there is an association 
between helminth infections, systemic inflammation and glucose metabolism, the 
causality in these relationships has not been demonstrated as yet. Therefore, we 
have initiated a large scale cluster randomized controlled trial (RCT) with the aim 
to assess the effect of anthelmintic treatment on insulin resistance, the hypothesis 
being that removing helminth infections will lead to a higher degree of insulin 
resistance. While study outcomes will be analysed at the individual participant 
level, a household cluster randomization was chosen to minimise contamination 
between treatment groups and therefore reinfection of treated individuals. 
sTUdY dEsign
study area 
The study area is located in Nangapanda, a sub-district of the Ende District of Flores 
Island, Indonesia [43,44]. Nangapanda is a semi-urban coastal area with a population 
of approximately 22.000 people being divided over 29 villages. Our study area 
includes three of these villages (Ndeturea, Ndorurea 1, Ndorurea, with a total 
population of 3698 people, from which most of the adult population are farmers. 
Previous studies have shown that this area is endemic for soil-transmitted helminth 
(STH) infections [45]. A detailed map of the study area has been published [43].
Trial design
The study is designed as a household-based cluster-randomized, double-blind 
trial with two arms. In one arm treatment is given with albendazole (single dose of 
400 mg) on 3 consecutive days, while the other arm consists of matching placebo 















































Pharmaceutical, Bandung, Indonesia). The treatment is provided every three 
months for a period of 1 year (total 4 rounds) to all household members except 
children below 2 years of age, while subjects aged 16 or above will undergo clinical 
and laboratory examination. Subjects with active treatment for diabetes mellitus, 
serious concomitant disease and pregnancy will be excluded.
The population was randomised by JWAS and JJH using   computer aided block 
randomization at  household level, utilizing Random Allocation Software to  assign 
treatment groups. Both study investigators and patients are blinded for treatment 
codes. The treatment code will be unblinded when all data needed for analysis 
are cleaned and entered into the database. An additional randomization was 
performed in a subgroup of individuals, who will undergo an oral glucose tolerance 
test and immunological studies in order to study glucose metabolism and immune 
mechanisms in more detail. For this subgroup, we aimed to select one subject 
per household and stratified by age group (16-36 years of age, 36-56 years of 
age, and >56 years of age) to ensure that sufficient numbers of all age groups are 
participating. Randomization was based on households.
Well trained community workers were recruited and trained to distribute the 
drugs. These workers were also trained to assist during clinical examination and 
sample collection and were involved in health promotion within the population. 
Community workers and research team members will directly supervise the 
study participants while taking the study medication, and will collect empty 
drug canisters at each visit to confirm compliance. Furthermore, assessment of 
side effects will take place during these visits and migration and death will be 
noted. Adverse events spontaneously reported by the patient or observed by the 
investigators, will be monitored throughout the study. After completion of the 
study, the whole study population will be treated with a single dose of albendazole 
(400 mg) for 3 consecutive days.
outcomes
As this study aims to assess the effect of anthelmintic treatment on whole-body 
insulin sensitivity, our primary outcome is a change in insulin resistance as assessed 
by HOMA-IR between both treatment arms after one year of treatment. Secondary 
outcomes are changes in body mass index and waist circumference, fasting plasma 
glucose, 2h-glucose levels after oral glucose tolerance test, HbA1c, serum lipid 
















































Sample size is calculated according to intention to treat analysis in which we will need 
1580 subjects in total. Based on our previous study [45] we assume that the average 
household size is 4 and that around 20% will be lost to follow up after one year. We 
use a significance level of 5% and a power of 80%. Correlations within households 
are taken into account by using the correction factor 1+(m-1) ICC, with m being the 
household size and ICC the intra-class correlation. The sample size is computed for 
a difference in mean between the two treatment groups of 0.18 and an ICC of 0.1.
For the subgroup of individuals undergoing an oral glucose tolerance test, a sample 
size of 335 subjects in total is calculated assuming that around 20% will be lost to 
follow up after one year and using a significance level of 5% and a power of 80%. 
The sample size is computed for a difference in mean of 10.3 mg/dL and a standard 
deviation of glucose level of 30 mg/dL.
mETHods
sample collection
At baseline all eligible subjects, aged 16 and above will be invited to visit the 
examination centre after an overnight fasting and to provide stool, blood and 
first morning urine samples. During this visit, participants education level and 
profession will be registered. After 1 year of treatment, follow-up sample collection 
will take place as shown in Table 1. 
clinical anthropometry assessment
Anthropometric measurements of body weight, height, waist and hip circumference 
are obtained using the National Heart, Lung, and Blood Institute (NHLBI) practical 
guidelines. To measure body weight a flat scale for mobile use (SECA Model 876, 
Seca Gmbh Co, Hamburg, Germany) is used, while a portable stadiometer (SECA 
Model 213, Seca Gmbh Co, Hamburg, Germany) is used to measure height. Waist 
and hip circumference are measured using ergonomic circumference measuring 
tape (SECA Model 201, Seca Gmbh Co, Hamburg, Germany).  In addition, body fat 
composition is measured using a Tanita body composition analyser (TBF-300A, 
Tanita Corp, Tokyo, Japan). Three blood pressure measurements (left arm, 
sitting upright position, after resting 5 minutes) are taken from each subject, 
using a digital sphygmomanometer (HEM-7200, Omron Healthcare Co, Ltd, 















































mercury sphygmomanometer (Gerhard Glufke Rudolf Riester GmbH & Co, 
Jungingen, Germany) and a 3MTM LittmannH Classic II S.E. Stethoscope (3M, 
St. Paul, Minnesota, USA). The average of three systolic/diastolic blood pressure 
measurements will be used for analysis.
Table 1. study schedule of the sugarspin project
outcome Baseline
3 monthly treatment 1 year
follow up1st 2nd 3rd 4th
Clinical Anthropometry X X
Parasitological examination X X
Metabolic parameters X X
Immunological parameters X X
Assessment of side effects X X X X X
parasitological examination
To assess intestinal helminth infection, stool containers are distributed and 
collected by health workers. Stool samples are examined by the Kato Katz method 
[46] for identification and quantification of STH eggs using 2 slides for each sample. 
An aliquot of the fresh stool samples is frozen at -20°C in the field and subsequently 
at -80°C in laboratories of the Departments of Parasitology at Leiden University 
Medical Center, Leiden, The Netherlands and Faculty of Medicine Universitas 
Indonesia, Jakarta, Indonesia for DNA extraction [43]. Part of the stool sample will 
be saved for potential future analysis of the microbiome. 
DNA isolation and helminth real-time PCR
DNA isolation from stool will be performed as described elsewhere [43], with some 
minor modifications. Real-time PCR will be performed to detect the presence of 
A. duodenale, N. americanus (hookworm), A. lumbricoides and T. trichiura using a 
method described previously [43] with some modifications. 
Blood collection 
Peripheral blood is collected into EDTA and SST Vacutainers (BD, Franklin Lakes, NJ, 
USA). Giemsa-stained peripheral blood smear is prepared to evaluate neutrophil 
and eosinophil count. In a subset of the study population, additional blood is 















































Switzerland) and Sodium Heparin Vacutainers (BD). Blood collected in PAXgene 
Blood RNA Tubes will be used to study RNA expression profiles, while blood 
collected in Sodium Heparin Vacutainers will be used for detailed immunological 
measurements as described below (section Immunological methods). All samples 
deriving from EDTA and SST Vacutainers (serum, plasma, cell pellet and whole 
blood) and all PAXgene Blood RNA Tubes are kept at -20°C at the Field Clinical 
Research Centre (FCRC) and will be sent on dry ice to University’s laboratory for 
storage at -80°C. 
metabolic parameters
Fasting blood glucose is measured in capillary blood using Breeze®2 glucose 
meters (Bayer Health Care LLC, Basel, Switzerland). An oral glucose tolerance 
test performed in a subset of the study population uses WHO protocol. [47,48] 
Glucose levels are measured in capillary blood using Breeze®2 glucose meters 
after overnight fasting and 2 hours after ingesting 75g of anhydrous glucose 
dissolved in 200 cc of water.  Insulin, HbA1c and lipid profiles will be measured in 
an internationally accredited laboratory.  HOMA-IR, a well-validated measure of 
insulin resistance will be calculated to estimate insulin resistance.[49] 
immunological methods
The immunological parameters that will be studied are 1) Total IgE levels as one 
of the markers of Th2 response and its relation to metabolic parameters, 2) 
Circulating pro and anti-inflammatory cytokines in order to study their relationship 
to metabolic parameters, 3) Antigen specific IgE and IgG to Ascaris lumbricoides 
to monitor antibody responses to one of the helminths studied as a marker of 
changing immune responses as a result of anthelmintic treatment, 4) Granulocyte 
(neutrophil and eosinophil) frequencies and their activation to assess whether 
granulocytes, in particular eosinophils which are associated with Th2 response, 
are linked to helminth infections and metabolic parameters, 5) Peripheral blood 
mononuclear cells (PBMC) subset analysis and polarisation by flow cytometry in 
order to assess the relationship between immune cell frequencies (T cell subsets, 
B cell subsets, monocyte subsets, NK cells and myeloid suppressor cells) in situ as 
well as after activation and metabolic parameters.
Total IgE
Total IgE will be measured using ELISA with rabbit anti-human IgE antibodies 















































(Vector Laboratories, Burlingame, CA, USA) as capture and detection antibodies, 
as described previously [43]. The World Health Organization standard of human 
serum IgE was used as a reference (National Institute for Biological Standards and 
Control). The results will be expressed in International Units (IU).
Circulating cytokines
Pro and anti-inflammatory cytokines (TNFα, IFNγ, IL-1, IL-6, IL-10, TGFβ) will be 
measured in serum samples using cytokines kit with high sensitivity.
Ascaris-specific IgE
Ascaris antigen will be prepared from Ascaris lumbricoides worms as described 
previously.[50] Maxisorp plates (Thermo Fisher Scientific, Roskilde, Denmark) will be 
coated overnight with 5 µg/ml Ascaris antigen in 0.1M carbonate buffer (pH 9.6).  Plates 
will be blocked for 1 hour with PBS containing 2% bovine serum albumin. Samples will 
be diluted 1/60 in 0.1 M Tris-HCl containing 0.05% Tween-20 and incubated overnight 
together with a pool of positive standard plasma containing 1X106 arbitrary units (AU) 
parasite specific IgE. After a washing step, goat anti-human IgE biotinylated antibodies 
(Vector) will be incubated followed by streptavidin-HRP (Sanquin, Amsterdam, the 
Netherlands). The color is developed by adding 3,3’,5,5’ tetramethylbenzidine (TMB) 





absorbance will be read at 450 nm in an automated plate reader. 
Ascaris-specific IgG isotypes
Maxisorp plates will be coated with Ascaris antigen as described for Ascaris 
specific IgE above. Blocking will be done using PBS containing 5% bovine serum 
albumin. Samples will be diluted 1/1000, 1/10, 1/5 or 1/25 for IgG1, IgG2, IgG3 
and IgG4 respectively, and a pool of positive standard plasma containing 1X106 
arbitrary units (AU) parasite specific IgG isotypes will be included in each plate. 
After overnight incubation, HRP-labelled anti human IgG isotypes (Sanquin) in PBS 
0.05% Tween-20 will be added for 4 hours incubation at 37°C using the following 
dilutions: 1/3000 for anti IgG1 (HP6188) and anti IgG4 (HP6196); 1/1000 for anti IgG2 
(HP6014) and anti IgG3 (HP6095). TMB substrate will be used to develop the color 
and the reaction will be stopped as described above.
Whole blood stimulation and fixed granulocyte cryopreservation
To study the expression of activation markers on granulocytes, 600 µl of 
heparinised venous blood is divided over 3 polystyrene tubes (200 µl/tube). 















































at 37°C is performed with medium/control, N-Formyl-Met-Leu-Phe (FMLP, 10-5 
M; Sigma, Saint Louis, MO, USA) or eotaxin (10-7 M; R&D systems, Abingdon, UK). 
Subsequently, 4 ml of FACS lysing solution (BD) is added and after an incubation 
period of 15 minutes at room temperature the red blood cells is lysed while white 
blood cells, including granulocytes, become fixed. Cells are washed with RPMI 
1640 containing 10% heat-inactivated FCS and then resuspended in RPMI 1640 
containing 10% of heat-inactivated foetal calf serum (FCS) and 10% dimethyl 
sulfoxyde (DMSO). Cryovials containing the cell suspension are placed at -80°C for 
minimum of 4 hours, followed by storage in liquid nitrogen until further analysis.
PBMC cryopreservation
Peripheral blood mononuclear cells (PBMCs) are isolated from heparinised venous 
blood using Ficoll density gradient centrifugation within 12 hours after blood 
collection. After isolation, cells are cryopreserved in RPMI 1640 containing 20% 
of heat-inactivated foetal calf serum (FCS) and 10% dimethyl sulfoxyde (DMSO). 
Cryovials containing the cell suspension are transferred to a freezing unit which is 
placed in a -80°C freezer for minimum of 4 hours. Subsequently, vials are stored in 
liquid nitrogen until analysis.
metabolomics for metabolic profiling
Urine samples and blood samples from heparinized blood are kept at -20°C at the 
FCRC and subsequently stored at -80°C at the University’s laboratory for possible 
future metabolomics measurements. The exploratory metabolomics analysis will 
be performed by 1H-NMR and LC-MS metabolomics,  a combination of NMR and 
LC-MS proposed for this study provides  a comprehensive coverage of metabolome 
and as such increase the probability finding physiologically meaningful associations 
within the data. 
data management and statistical analyses
A centrally accessible database designed in Microsoft Access is established and 
the data is entered by well-trained data entry personnel. Descriptive data will be 
summarized for continuous variables as mean +/- SD for normally distributed data 
and median (range) for non-normally distributed data. Categorical data will be 
expressed as proportions.
The effect of anthelmintic treatment on change in insulin resistance (HOMA-IR) 















































after 1 year of treatment using mixed models to account for the correlation within 
households, in which relevant confounders (including age, gender, BMI, village) 
are entered.  The characterization of immune responses to helminth infections and 
systemic inflammation will be assessed by measuring cytokine profiles. Moreover, 
for these analyses multilevel modelling will be used and the use of longitudinal 
data will take repeated measurement into account.[51] The mediation of helminth’s 
effects on insulin resistance via immune responses will also be assessed.
Ethical approval, trial registration and consent
This study has been approved by The Health Research Ethical Committee, Faculty 
of Medicine, Universitas Indonesia Cipto Mangunkusumo Hospital, Jakarta, 
Indonesia (reference number:549/H2.F1/ETIK/2013). It has also been filed by the 
ethics committee of Leiden University Medical Center and is registered as a clinical 
trial ref: ISRCTN75636394 (http://www.controlled-trials.com/isrctn/pf/75636394). 
The local health authorities have been informed about this study and have given 
 
SUGARSPIN Study Protocol 30
Description of the population recruited 
So far, the study has provided the following data (Figure 1). At baseline, a total of 3698 individuals were 
registered in 752 households. Of the 2428 subjects aged 16 years or older, 1669 subjects were eligible with 
consent for examination. For the oral glucose tolerance test and immunological studies 339 subjects were 

























Figure 2 shows the age pyramid of both the whole population in the study area and the study population. In 
this area farming and fishing are the traditional source of income while some individuals engage in jobs at 




(n=752 HH, n=3698 subjects)GPS mapping 
Treatment A* 
(n=377 HH, n=1825 subjects)
Treatment B* 
(n=375 HH, n=1741 subjects)
Subjects ≥ 16 years 
(n=374 HH, n=1251 subjects)
Eligible with consent for 
examination 
(n= 353 HH, n=872 subjects)
Subjects  ≥ 16 years 
(n=373 HH, n=1155 subjects)
Eligible with consent for 
examination 
(n=329 HH, n=797 subjects)
*Households were assigned to three monthly treatment with albendazole or placebo for 1 year
**For the oral glucose tolerance test (OGTT) and immunological studies, a random selection was made and 339 
individuals were invited to participate. 
In OGTT subgroup**
(n=167 subjects)
Not in OGTT subgroup
(n=705 subjects)
Study outcome 1 year post treatment
In OGTT subgroup**
(n=172 subjects)









(n=752 HH, n=3566 subjects)
Pregnant n=22 subjects
<2 years old n=110 subjects
<16 years =586 subjects<16 years =574 subjects





















































































The education level of the majority of subjects in the study population is elementary school (33%), followed by 
senior high school (22%), and junior high school (16%), while 11% has college or university degrees. Moreover, 
18% of the subjects is illiterate, either not educated at all or dropped out from elementary school (Figure 4). A 









Figure 2. Age pyramid. Age pyramid of all individuals living in the study area in Nangapanda, Flores Island, 
Indonesia (n=3698 subjects, 52% female) (A), and of study participants (n=1669 subjects, 60% female) (B).  
A 
B 
figure 2. age pyramid. Age pyramid of all individuals living in the study area in Nangapanda, Flores 
Island, Indonesia (n=3698 subjects, 52% female) (A), and of study participants (n=1669 subjects, 60% 
female) (B).
their approval and support. The study, its benefits and risks are explained to the 
population and consent forms are distributed to be signed by the subjects who are 
willing to participate in this study. They are informed that they can withdraw from 
the study at any time, for any reasons and without any consequences. 
description of the population recruited
So far, the study has provided the following data (figure 1). At baseline, a total 
of 3698 individuals were registered in 752 households. Of the 2428 subjects aged 
16 years or older, 1669 subjects were eligible with consent for examination. For the 
oral glucose tolerance test and immunological studies 339 subjects were randomly 















































figure 3. Job distribution. At baseline, profession was assessed for study participants (n=1669 
subjects).
figure 4. Education level. At baseline, education level was assessed for study participants (n=1669 
subjects).
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Figure 4. Education level. At baseline, education level was assessed for study participants (n=1669 
subjects).  
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figure 2 shows the age pyramid of both the whole population in the study area 
and the study population. In this area farming and fishing are the traditional source 
of income while some individuals engage in jobs at government offices or in the 
private sector (figure 3), a similar distribution is seen in the total population.
The education level of the majority of subjects in the study population is elementary 
school (33%), followed by senior high school (22%), and junior high school (16%), 
while 11% has college or university degrees. Moreover, 18% of the subjects is 
illiterate, either not educated at all or dropped out from elementary school 
(figure 4). A similar distribution of education levels is seen in the total population.
discUssion
The SUGARSPIN trial is the first and currently the only longitudinal study investigating 
the effects of anthelmintic treatment on whole-body insulin sensitivity. This 
placebo-controlled trial enables us for the first time to investigate the causal 
relationship between helminth infections, systemic inflammation and glucose 
metabolism in humans. In addition, this study will provide data on anthelmintic 
treatment efficacy and effectiveness in a large population in a developing country 
like Indonesia. 
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Background. Emerging evidence suggests that helminth infections are 
associated with lower insulin resistance (IR). Current deworming programs 
might remove this helminth-associated protective effect. Therefore, we 
evaluated the anthelmintic treatment effect on changes in IR.
methods. We conducted a double-blind, household-cluster-randomized, 
placebo-controlled clinical trial on Flores island, Indonesia, an area endemic 
for soil-transmitted helminths (STHs). All subjects received four rounds of 
albendazole or matching placebo with 3-month intervals, for 3 consecutive 
days. The primary outcome was the change in homeostatic model assessment 
of IR (HOMA-IR) in those aged ≥16 years. An intention-to-treat analysis was 
performed involving all subjects and ad hoc in the helminth-infected subjects. 
results. We examined 797 (in 329 households) and 872 (in 353 households) 
subjects, who were assigned randomly into the albendazole and placebo 
arm, respectively. Albendazole was associated with a significant reduction 
in STH prevalence, total Immunoglobulin E (IgE) and eosinophil count. 
Whereas albendazole had no effect on IR [estimated treatment effect, 0.006 
(95% confidence interval, -0.010 – 0.021), p=0.48] at the community level, 
it was associated with a significant increase in IR [0.031 (0.004 – 0.059), 
p=0.04, p-value for interaction=0.01] among helminth-infected subjects as 
detected by microscopy. Pathway analysis suggested that this might in part 
be due to an increased body mass index or a reduced eosinophil count.
conclusions. Anthelmintic treatment reduces STH prevalence, total IgE and 
eosinophil count but has no effect on IR at the community level. In helminth-
infected subjects, treatment significantly increases IR, highlighting the need 
for metabolic health monitoring with ongoing deworming programs. 
clinical Trials registration. ISRCTN 75636394.






































The increasing prevalence of type 2 diabetes mellitus (DM2) is a major health 
concern worldwide, in particular in low- and middle-income countries (LMIC).
[1] The rapid socio-economic development in these countries has led to a shift 
in dietary habits and infrastructure which promotes overnutrition and decreased 
physical activity,[2] ultimately increasing the risk for DM2. DM2 is characterized by 
increased insulin resistance (IR). Although the pathophysiology of DM2 is complex 
and involves several defects,[3] there is evidence that in addition to an altered 
energy balance, chronic low-grade systemic inflammation plays a key role, linking 
the immune system and the impairment in metabolic homeostasis.[4]
Helminth infections, which are still endemic in many LMIC,[5] are associated with 
skewed immune responses towards type-2 and regulatory immune responses.[6] 
This may lead to a decreased systemic inflammation and consequently increased 
whole-body and tissue-specific insulin sensitivity.[7] In addition, helminths are 
associated with a lower body mass index (BMI),[8] which may be beneficial in terms 
of IR. Helminths may therefore improve insulin sensitivity via immunological and 
non-immunological pathways.[6, 9, 10] 
Interleukin (IL)-4[11] and IL-10,[12] key cytokines in helminth infections, have 
been shown to regulate peripheral nutrient metabolism and insulin sensitivity.[11] 
Recent studies in animal models of diet-induced obesity [13-17] have also shown 
that helminth infections [13, 15-17] and helminth-derived molecules [14, 16-18] 
can increase insulin sensitivity through direct and indirect control of metabolic 
pathways.[18] Furthermore, several population based studies have reported a 
lower DM2 risk in subjects with previous [19, 20] or current [21, 22] chronic helminth 
infections. In a previous study on Flores island in Indonesia, we reported that 
chronic soil-transmitted helminth (STH) infections were associated with lower 
whole-body IR, independent of BMI.[8] 
However, all human studies performed so far have been cross-sectional, preventing 
any insight on a causal relation between helminth infections and IR. Therefore, we 
performed a cluster-randomized controlled trial (RCT) of anthelmintic treatment 
in an area endemic for STHs, studying the hypothesis that a reduction of helminth 







































We conducted a household-based cluster-randomized double-blind trial in 
3 villages in Nangapanda, Ende, Flores island, Indonesia. The trial was approved by 
the ethics committee of Faculty of Medicine, Universitas Indonesia (FKUI), filed by 
the ethics committee of Leiden University Medical Center (LUMC), and registered 
as a clinical trial (http://www.isrctn.com/ISRCTN75636394). The protocol was 
published previously.[23]
participants
All subjects in the study area, except children <2 years of age and pregnant women, 
were included in the trial to avoid cross-contamination between household 
members. Subjects aged ≥16 years underwent clinical and laboratory examination, 
excluding subjects with active treatment for diabetes mellitus and serious 
concomitant diseases. 
study design and Treatments
After obtaining written informed consent, the population was randomised by 
household blocks using Random Allocation Software for assignment to treatment. 
Both study investigators and participants were blinded for the treatment code. 
After randomisation, all study subjects received a tablet of albendazole (400 mg) or 
matching placebo (both manufactured by PT Indofarma Pharmaceutical, Bandung, 
Indonesia) for three consecutive days with direct supervision. This treatment regimen 
was given 4 times with 3-month intervals (week 9-10, 21-22, 33-34, and 45-46). Clinical 
measurements, as well as blood and stool sample collection, were performed during 
the first 8 weeks before the start of the drug administration(baseline or t=0) and 6 
weeks after the last  drug administration (follow-up or t=52 weeks) (supplementary 
figure 1). After completion of the study, the whole study population was treated with 
a tablet of albendazole (400 mg) for 3 consecutive days.
study procedures and outcomes
All clinical measurements and blood sample collections were performed after 
an overnight fast. Detailed information on study procedures are available at the 
supplementary appendix. In brief, body weight, height, waist circumference, 
hip circumference were measured, from which BMI and Waist-to-hip-ratio were 
calculated. Fasting blood glucose was determined in capillary blood. All sera, 





































stored at −80°C. Insulin, haemoglobin A1c (HbA1c), total cholesterol, high-density 
lipoprotein cholesterol (HDL-C), triglycerides and high-sensitivity C-reactive 
protein (hs-CRP) were measured pairwise (baseline and follow-up) in the same 
analytical runs at the LUMC. A Giemsa-stained peripheral thin blood smear was 
read at FKUI to assess the differential white blood cell count, resulting in a relative 
percentage of basophils, eosinophils, neutrophils, lymphocytes and monocytes. 
Total IgE was measured at LUMC as described previously.[24]
Fresh stool samples were examined by microscopy using the Kato-Katz method to 
detect STHs (hookworm, Ascaris lumbricoides, and Trichuris trichiura). Multiplex 
real-time polymerase chain reaction (PCR) was performed to simultaneously 
detect the presence of hookworm (Ancylostoma duodenale, Necator americanus), 
Ascaris lumbricoides, Trichuris trichiura, and Strongyloides stercoralis. Stool 
samples were considered positive by PCR when cycle threshold (Ct) values were 
<50, and further grouped into 3 categories: Ct <30, 30 to <35, and ≥35 representing 
a high, moderate and low DNA load, respectively.[25] 
Primary outcome was IR, assessed using the homeostatic model assessment of 
IR (HOMA-IR), a well-validated measure of whole body IR in humans (HOMA-IR= 
fasting serum insulin x fasting glucose / 22.5).[26] Secondary outcomes included 
BMI, waist circumference, fasting blood glucose, HbA1c, lipid levels, total IgE, 
eosinophil count, hs-CRP and prevalence of STHs as assessed by microscopy and 
stool PCR. Adverse events reported by subjects or observed by the investigators 
were monitored during the trial.
statistical analysis
The sample size was calculated according to intention-to-treat analysis. Based on 
our previous study,[27] we assumed that the average household size is 4 and that 
around 20% of participants would be lost to follow-up after one year. We used a 
significance level of 5% and a power of 80%. Correlations within households were 
taken into account by using the correction factor 1 + (m-1) ICC, with m being the 
household size and ICC the intra-class correlation. The sample size was calculated 
to aim at a difference in mean HOMA-IR between the 2 treatment groups of 0.18 
and an ICC of 0.1 indicating 1580 subjects in total. 
For continuous variables, normally distributed data were summarized as mean and 
standard deviation [mean (SD)], while non-normally distributed data (HOMA-IR, 





































mean and 95% confidence interval (CI), and log-transformed for analyses. 
HOMA-IR and hsCRP were log transformed as log
10
(1+[value]). Categorical data 
were expressed as proportions. 
The effect of anthelmintic treatment on HOMA-IR was assessed at community 
level using an intention-to-treat approach, using mixed models to account for the 
correlation within households. As an ad hoc analysis, we stratified by infection 
status by including helminth infection status (no infection, any infection) at 
baseline and its interaction with treatment into the model. We also stratified by the 
number of helminth species a subject was infected with, by including the number 
of helminth species (no infection, single infection, multiple infection) at baseline 
and its interaction with treatment into the model. Two random effects were used: 
to model clustering within households a random household specific intercept was 
used and to model correlation within subjects random subject-specific intercept 
was used. Parameter estimates for treatment effect and 95% CIs were reported. The 
reported p-values were obtained using a likelihood ratio test comparing the model 
with and without the treatment effect. We used the same model for secondary 
outcomes. For the binary outcome (helminth infection status), a logistic model 
was used with random household effects and random subject effects. All models 
were fitted using the lme4 package (R software).
rEsUlTs
Between 1 April 2014 and 3 June 2014, we initially included 752 households with 
3566 subjects in the trial. Randomization resulted in 1825 subjects assigned to 
placebo and 1741 subjects to albendazole (377 and 375 households, respectively). 
The overall trial profile is shown in figure 1, with a total of 1669 subjects aged 16 
and above who were examined at baseline [872 subjects (353 households) and 797 
subjects (329 households) in the placebo and the albendazole group respectively]. 
Baseline (t=0) characteristics were similar between both treatment arms (Table 1). 
The overall loss to follow-up, from baseline to 52 weeks, was 18.9%. The main 
reason for loss to follow-up was permanent or temporary movement out of the 
village for employment or study. Those who moved out and refused to come for 
follow-up, were younger in comparison to the whole population. There were no 
significant differences between both treatment arms in terms of loss to follow-up 
(supplementary Table s1). With respect to compliance, 87.9% (1189/1353) of the 










































Figure 1. Trial profile. #Baseline data (t=0) were collected during the first 8 weeks before the start of the drug 
administration. $Single dose of albendazole or matching placebo was given for 3 consecutive days to all 
household members, except children <2 years of age and pregnant women. *Other reasons of lost to follow-up 
were harvesting crops, working on funeral ceremonies, severely ill, hospitalized, and nursing mother. 




Between 1 April 2014 and 3 June 2014, we initially included 752 households with 3566 subjects in the trial. 
Randomization resulted in 1825 subjects assigned to placebo and 1741 subjects to albendazole (377 and 375 
households, respectively). The overall trial profile is shown in Figure 1, with a total of 1669 subjects aged 16 
and above who were examined at baseline [872 subjects (353 households) and 797 subjects (329 households) 
in the placebo and the albendazole group respectively]. Baseline (t=0) characteristics were similar between 
both treatment arms (Table 1).  
 
  
figure 1. Trial profile. #Baseline data (t=0) were collected during the first 8 weeks before the 
start  the drug administration. $Singl  d se of albendazole or ma ching placebo was given for 
3 consecutive ays to all household members, except childr n <2 ye rs of age and pregna t women. 
*Other reasons of lost to follow-up were harvesting crops, working on funeral ceremonies, severely 
ill, hospitalized, and nursing mother. Abbreviations: HH, households; FU, follow-up.
the albendazole and the placebo group, respectively]. We collected stool samples 
from 92.0% (1535/1669) of the subjects at baseline and 89.9% (1217/1353) of the 
subjects at follow-up. Data to calculate HOMA-IR were available for 1604 subjects 
at baseline, and for 1272 subjects at follow-up. Sixteen subjects who were receiving 





































Table 1. Baseline characteristics of study population
characteristic no. placebo no. albendazole
Age, y, mean (SD) 872 42.5 (15.7) 797 42.5 (15.7)
Sex, female, No. (%) 872 534 (61.2) 797 478 (60.0)
Body mass index, kg/m2, mean (SD) 860 22.4 (4.2) 790 22.4 (4.0)
Waist circumference, cm, mean (SD)
Female 532 76.5 (12.6) 476 77.0 (12.6)
Male 333 76.5 (11.6) 317 76.6 (11.3)
Waist-to-hip-ratio, mean (SD)
Female 507 0.88 (0.07) 473 0.89 (0.08)
Male 317 0.94 (0.07) 315 0.94 (0.07)
Systolic BP, mmHg, mean (SD) 871 129.3 (23.4) 765 129.5 (23.8)
Diastolic BP, mmHg, mean (SD) 871 76.4 (12.1) 765 76.5 (12.1)
Total cholesterol, mmol/L, mean, (SD) 836 4.9 (1.1) 764 4. 9 (1.1)
HDL  cholesterol, mmol/L, mean, (SD)
Female 517 1.3 (0.4) 457 1.3 (0.4)
Male 319 1.1 (0.3) 307 1.1 (0.3)
LDL cholesterol, mmol/L, mean, (SD) 836 3.0 (0.9) 763 3.0 (0.9)
Triglycerides, mmol/L, mean, (SD) 836 1.4 (0.7) 764 1.5 (0.7)
HbA1ca, mmol/mol, mean (SD) 715 32.5 (9.0) 683 32.3 (8.5)
Fasting blood glucose, mmol, mean, (SD) 836 5.5 (1.6) 768 5. 5 (1.6)
Fasting Insulin, mU/L, GM (95%CI) 836 3.5 (3.2 – 3.7) 768 3.5 (3.3 – 3.8)
HOMA-IR, GM (95%CI) 836 1.09 (1.02 – 1.15) 768 1.08 (1.01 – 1.14)
hs-CRP, mg/L, GM (95%CI) 836 1.26 (1.16 – 1.36) 764 1.26 (1.16 – 1.37)
Total IgE, IU/mL, GM (95%CI) 835 557.2 (498.1 – 623.3) 766 601.6 (534.8 – 676.7)
Eosinophil count, %, GM (95%CI) 829 5.9 (5.6 – 6.1) 763 6.1 (5.8 – 6.4)
Helminth infection by microscopy, No. (%) 655 283 (43.2) 602 251 (41.7)
Single 185 (28.2) 160 (26.6)
Multiple 98 (15.0) 91 (15.1)
Helminth infection by PCR, No. (%) 783 425 (54.3) 710 393 (55.4)
Single 256 (32.7) 252 (35.5)
Multiple 169 (21.6) 141 (19.9)
Abbreviations: BP, blood pressure; CI, confidence interval; GM, geometric mean; HDL, high-density lipoprotein; 
HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment for insulin resistance; hs-CRP, high-
sensitivity C-reactive protein; IgE, immunoglobulin E; LDL, low-density lipoprotein; PCR, polymerase chain 
reaction; SD, standard deviation. aAfter excluding subjects with unidentified hemoglobinopathy on the Tosoh 
G8 high-performance liquid chromatography analyzer (13.9% [116/831] in the placebo group and 10.5% [80/763] 





































figure 2. The effect of albendazole treatment on the prevalence and intensity of soil-
transmitted helminths. Percentage of hookworm-, Ascaris lumbricoides-, and Trichuris trichiura-
infected subjects at baseline (t=0) and following treatment (t=52 weeks), in placebo and albendazole 
treatment arms, as detected by microscopy (n=1011; A) and polymerase chain reaction (n=1144; B). 
Albendazole treatment was associated with a  significant reduction of hookworm, A. lumbricoides 
and T. trichiura. p-values were calculated using a logistic model with random household effects and 
random subject effects. *corresponds to p-value <0.0001.
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Effect of Treatment at the Community Level 
Albendazole treatment reduced the percentage of subjects with any helminth infection as assessed by either 
microscopy [41.7% (251/602) to 5.6% (27/486) in the albendazole arm vs 43.2% (283/655) to 34.4% (181/526) 
in the placebo arm, p<0.0001] or PCR [55.4% (393/710) to 11.3% (62/550) in the albendazole arm vs 54.3% 
(425/783) to 46.8% (278/594) in the placebo arm, p<0.0001]. The highest reduction was seen for hookworm, 
followed by A. lumbricoides and T. trichiura infection (Figure 2). When assessing the infection intensity in 
categories based on PCR, albendazole treatment resulted in a reduction in intensity across these three 
helminths species with the least effect on T. trichiura infection (Figure 2B). S. stercoralis prevalence, which was 
already low, was eliminated in the albendazole group (Supplementary Table S2). 
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three helminths species with the least effect on T. trichiura infection (figure 2B). 
S. stercoralis prevalence, which was already low, was eliminated in the albendazole 
group (supplementary Table s2).
At the community level, neither HOMA-IR nor BMI, waist circumference, fasting 
blood glucose, HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, 
triglycerides and hsCRP were found to be affected by albendazole treatment 
(Table 2). However, the significant reduction of infection prevalence and intensity 
by albendazole treatment, was accompanied by a significant decrease in total 
IgE level [Estimated treatment effect (95% CI), p value, -0.066 (-0.094 – -0.037), 
p<0.0001] and eosinophil count [-0.057 (-0.086 – -0.028), p=0.0001] (Table 2). 
Effect of Treatment in sTH-infected subjects
Next, the effect of treatment was assessed only in those who were infected with 
helminths at baseline, as detected by microscopy. Albendazole treatment resulted 
in a significant increase in HOMA-IR [0.031 (0.004 – 0.059), p=0.04] (figure 3.a). 
This effect was greater in comparison to subjects without helminth infections at 
baseline (p=0.01 for the interaction between helminth infection status at baseline 
and treatment). Moreover, with an increasing number of helminth species infecting 
a subject at baseline, there was a gradual increase in HOMA-IR after treatment. 
Thus, whereas we saw no significant effect of treatment among those with no 
infection [-0.013 (-0.035 – 0.010), p=0.28] or those infected with single species 
[0.017 (-0.017 – 0.050), p=0.34], treatment in those infected with multiple helminth 
species resulted in a significantly higher HOMA-IR [0.061 (0.015 – 0.106), p=0.02, 
p value for interaction=0.005] (figure 3.a). These effects were also reflected for 
BMI (figure 3.B), eosinophil count (figure 3.c), and total IgE level (figure3.d), but 
not for HbA1c, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides 
and hsCRP levels. Pathway analysis showed that adjustment for BMI, eosinophil 
count but not total IgE level, attenuated the treatment effect on HOMA-IR among 
helminth-infected subjects (supplementary Table s3).
When using PCR to detect STH infection, a significant increase of HOMA-IR was 
only observed among subjects who were infected with multiple helminth species 
at baseline (supplementary figure s2.a). A significant increase of BMI was also 
observed in these subjects (supplementary figure s2.B).The group of subjects 
infected with multiple helminth species had a significantly higher infection 
intensity in comparison to the group of subjects infected with single helminth 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































RCT on Helminths and Insulin Resistance 
 
 
Figure 3. Effect of albendazole treatment on homeostatic model assessment for insulin resistance 
(HOMA-IR), body mass index (BMI), total immunoglobulin E (IgE), and eosinophil count, stratified 
by the number of helminth species carried by infected subjects at baseline as detected by 
microscopy. Effect of albendazole treatment on HOMA-IR (n = 1211; A), BMI (n = 1233; B), total IgE (n 
= 1209; C), and eosinophil count (n = 1200; D), stratified by the number of helminth species infecting 
subjects at baseline, as detected by microscopy. The estimated treatment effects are displayed with 
the corresponding 95% confidence interval. Circle, infected with at least 1 helminth species; square, 




Adverse events were reported in 3.9% (31/797) and 2.6% (23/872) of subjects in the albendazole and 
the placebo group respectively. Abdominal pain was the most commonly reported complaint [35% 
(11/31) vs 13% (3/23) in the albendazole and the placebo group respectively]. Other commonly 
reported complaints were diarrhea and nausea, which were similar in both treatment arms. 
 
  
figure 3. Effect of albendazole treatment on homeostatic model assessment for insulin 
resistance (Homa-ir), body mass index (Bmi), total immunoglobulin E (igE), and eosinophil 
count, stratified by the number of helminth species carried by infected subjects at baseline 
as detected by microscopy. Effect of albendazole treatment on HOMA-IR (n = 1211; a), BMI 
(n = 1233;  B), total IgE (n = 1209; c), and eosinophil count (n = 1200; d), stratified by the number 
of helminth species infecting subjects at baseline, as detected by microscopy. The estimated 
treatment effects are displayed with the corresponding 95% confidenc  int rval. Circl , infected 
with at least 1 helmi th species; square, no infection; triangle, infected wit  1 helminth species; 
inverse triangle, i f t  with >1 helminth species.
adverse Events
Adverse events were reported in 3.9% (31/797) and 2.6% (23/872) of subjects in the 
albendazole and the placebo group respectively. Abdominal pain was the most 
commonly re or ed complaint [35% (11/31) vs 13% (3/23) in the alb ndazole and the 
placebo group respectively]. Other commonly reported complaints were diarrhea 
and nausea, which were similar in both treatment arms.
discUssion 
Here, we report the first cluster-randomized trial in humans investigating the causal 
relationship between helminth infections and whole-body IR in an area endemic for 
STHs. We found that after 12 months of follow-up, 4 rounds of anthelmintic treatment 





































BMI, waist circumference, fasting blood glucose, HbA1c, serum lipid levels and hs-CRP 
at the community level, when all participants irrespective of their helminth status 
were included in the analysis. This despite the fact that the prevalence and infection 
intensity of STHs, as well as its associated type 2 immune responses, measured by total 
IgE and eosinophil count, were significantly reduced in albendazole-treated subjects. 
When considering helminth-infected subjects, we observed that albendazole 
treatment resulted in a significant increase of IR among helminth-infected subjects 
when infection was detected by microscopy. Moreover, the effect of treatment on 
IR was stronger in those infected with multiple STH species at baseline compared 
to those with a single STH infection. We observed a similar pattern of the treatment 
effect on BMI. Even though significant, it is important to note that the magnitude 
of the effect of 1 year deworming on IR was modest. The effect of deworming 
in increasing IR seemed to be partly mediated through an increase in BMI, as 
adjustment for BMI, a strong predictor of IR,[28]  attenuated the treatment effect 
on IR. Similar to BMI, eosinophil count and total IgE were significantly decreased in 
helminth infected subjects and this was stronger in those with multiple helminth 
infections. The possible importance of eosinophils in IR, shown in animal models 
[13, 14, 16, 17] and in 1 epidemiological study,[29] is also seen in our study as 
correction for eosinophil count reduced the treatment effect on IR. 
When infection was assessed by PCR, which in comparison to the Kato Katz 
method, has a better ability to detect low intensity infections that may be clinically 
less relevant,[25] we only observed a significant increase in IR in the group of 
subjects who were infected with multiple helminth species at baseline. The 
infection intensity (DNA load) in this group of subjects was significantly higher 
than in those infected with a single STH species. Albendazole treatment led to a 
strong reduction of infection intensity in those infected with multiple STH species, 
which might explain the significant increase in IR following albendazole treatment. 
The observed modest increase of IR after treatment among helminth-infected 
subjects, as detected by microscopy, could also contribute to the lack of a 
significant effect of albendazole treatment on IR at the community level. Two 
recent meta-analysis on deworming in children support this notion as they show 
that whereas a mass deworming approach, thus irrespective of helminth infection 
status, resulted in no change in weight gain, targeted anthelmintic treatment of 





































However, several other explanations for the absence of a treatment effect on 
IR at the community level need to be considered. Although our study design 
was successful in lowering STH infection prevalence and its associated Th2 
responses, it is possible that longer treatment and follow up would show stronger 
effects. It is also possible that both immune and non-immune-related effects of 
helminths on IR are not only associated with current helminth infections [8] but 
also with exposure to helminth infections in the past and therefore sustained.
[13, 19] The causal relationship between helminth infection and IR, as found in 
the subgroup of infected subjects, might have a relatively small contribution to 
the multifactorial pathogenesis of IR.[28] Therefore, longer follow-up studies 
involving assessment of other more established factors, such as diet and physical 
activity,[28] will be needed to investigate this. 
The use of PCR in our study, in addition to microscopy for detection of helminths, 
has helped us realize that the burden of infections, in terms of the number of 
helminth species as well as  the infection intensity (DNA load), might influence 
the effect of anthelmintic treatment on IR. Deworming in subjects with increasing 
burden of infections resulted in an increasing change in IR. In addition, treatment 
of uninfected subjects, as assessed by either microscopy or PCR, did not influence 
IR, which suggests that an undetectable or a low level of helminth infection might 
be irrelevant for IR. The question whether a high burden of helminth infection 
causes different modulating effects on the immune system or energy balance, 
remains to be answered.
In conclusion, intensive anthelmintic treatment in an STH endemic area significantly 
reduces both the STH infection prevalence and intensity, as well as its related 
type 2 responses. This treatment does not lead to an increase of whole-body IR 
at the community level, but it does increase IR among those with a microscopy-
detected STH infection. Studies are needed to determine the long term metabolic 
consequences of anthelmintic treatment in communities where STH are highly 
prevalent. However, in terms of policy, countries implementing helminth control 
programmes need to be aware that this may exacerbate or accelerate the 
deterioration in metabolic health, and that education and prevention strategies for 
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All clinical measurements and blood sample collections were performed after 
an overnight fast. Anthropometric measurements of body weight (SECA Model 
876, Seca Gmbh Co, Hamburg, Germany), height (SECA Model 213, Seca Gmbh Co, 
Hamburg, Germany), waist and hip circumference (SECA Model 201, Seca Gmbh 
Co, Hamburg, Germany) were obtained using the National Heart, Lung, and Blood 
Institute (NHLBI) practical guidelines by a team of trained researchers. BMI was 
calculated as weight in kg divided by square of height in meter, while Waist Hip Ratio 
(WHR) was calculated as waist circumference divided by hip circumference. Three 
blood pressure measurements (left arm, sitting upright position, after resting 
5 minutes) were taken from each subject, using a digital sphygmomanometer 
(HEM-7200, Omron Healthcare Co, Ltd, Kyoto, Japan). The average of all three 
measurements was used for analysis.
Fasting blood glucose was measured in capillary blood using Breeze®2 glucose 
meters (Bayer Health Care LLC, Basel, Switzerland). All sera, plasma and whole 
blood samples were frozen at −20°C in the field study centre and subsequently 
stored at −80°C at the Department of Parasitology of FKUI and LUMC. Insulin, 
HbA1c, total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides 
and high-sensitive C-reactive protein (hsCRP) were measured pairwise (baseline 
and follow-up) in the same analytical runs at the Department of Clinical Chemistry 
and Laboratory Medicine at LUMC, which is ISO 15189:2012 accredited. Accuracy of 
test results is periodically and independently verified in EQA-schemes organized 
by the Dutch EQA-organization, the SKML.
Serum insulin concentrations were determined by a solid-phase, enzyme-
labeled chemiluminescent immunometric assay (Siemens IMMULITE 2000XPi). 
The measuring range of the insulin assay was 2–300 mU/L (CV
a 
<7% at all levels). 
IR was assessed by HOMA-IR, a well-validated measure of whole body IR in 
humans (HOMA-IR = fasting serum insulin x fasting glucose / 22·5).[26] HbA1c was 
measured using a cation-exchange chromatography (IC)-based high performance 
liquid chromatogtaphy (HPLC) assay (Tosoh G8 HPLC Analyzer, from Tosoh 
Corporation, Tokyo, Japan and distributed through Sysmex in the Netherlands), 
with a measuring range of 20–125 mmol/mol Hb (CV
a
<5% at all levels). Test results 





































non-porous ion exchange HPLC-column and four-steps buffer gradient enables a 
clear separation of HbA1c from other fractions and haemoglobin variants such as 
HbC, HbD and HbS. As these variants can be detected, the software automatically 
corrects the HbA1c results for these variants. However, other variants which may 
typically be present in non-Caucasian populations, are not detected and lead to 
inaccurate HbA1c results. Therefore, all chromatograms were visually inspected 
by experienced technicians in order to detect the unidentified Hb-variants. 
HbA1c results from unidentified Hb-variants were excluded as these test results 
were inaccurate. 
Total cholesterol, HDL-cholesterol and triglycerides assays were based on 
enzymatic colorimetric methods (Modular P analyzers, Roche Diagnostics, 
Mannheim, Germany). The measuring range of total cholesterol, HDL-cholesterol 
and triglycerides were 0·08–20·7 mmol/L (CV
a
<2%), 0·08–3·10 mmol/L (CV
a
<2%) 
and 0·05–11·4 mmol/L (CV
a
<5%), respectively. Lipid test results are standardized 
to internationally recognized CDC Reference Measurement Systems. Low-density 
lipoprotein (LDL)-cholesterol (in mmol/L) was calculated using The Friedewald 
formula, [LDL-chol, mmol/L] = [Total chol] - [HDL-chol] - (0·456 X [TG]). A latex-
enhanced immunoturbidimetric method was used to measure hsCRP on Roche 
Modular P-instrumentation, the measuring range being 0·1–20·0 mg/L.  HsCRP 
test results are ERM-DA470k/IFCC standardized.  
A Giemsa-stained peripheral thin blood smear was read at the Department of 
Clinical Pathology, FKUI to assess differential white blood cell count, resulting in 
a relative percentage of basophils, eosinophils, neutrophils, lymphocytes and 
monocytes. Total IgE was measured at the Department of Parasitology, LUMC 
using ELISA with rabbit anti-human IgE antibody (Ab) (Dako, Glostrup, Denmark) 
as capture Ab and goat anti-human IgE biotinylated Ab (Vector Laboratories, 
Burlingname, CA, USA) as detection Ab.[24] 
Fresh stool samples were examined by the Kato Katz method to identify and 
quantify STH (hookworm, Ascaris lumbricoides and Trichuris trichiura) eggs using 
2 slides for each sample. Aliquots of fresh stool samples were frozen at −20°C in the 
field study centre and subsequently at −80°C at the Department of Parasitology 
of FKUI and LUMC for DNA extraction. Stool DNA isolation and real-time PCR 
were performed pairwise (baseline and follow-up). DNA isolation from stool was 
performed as described elsewhere,[24] with an additional step of bead beating 





































extraction. Multiplex real-time PCR was performed to simultaneously detect the 
presence of hookworm (Ancylostoma duodenale, Necator americanus), Ascaris 
lumbricoides, Trichuris trichiura and Strongyloides stercoralis using a method 
described previously[24] with some modifications, adding the T. trichiura primers 
and probe, and combining the fluorescence of A. duodenale and N. americanus as 
one reading of hookworm. Stool samples were considered positive by PCR when 
cycle threshold (Ct) values were below 50. Positive Ct values were further grouped 
into 3 categories: Ct<30, 30≤Ct<35 and Ct≥35 representing a high, moderate and 
low DNA load, respectively.[25] An additional grouping was made based on the 
number of different STH species that subjects were infected with: no infection, 
single infection (one of the four STHs: hookworm, A.lumbricoides, T.trichiura, 





































figure s1. Trial time frame. Baseline data (t=0) were collected during the first 8 weeks before the 
start of the drug administration. Treatment regimen was given 4 times with three months time 
intervals (week 9-10, 21-22, 33-34, and 45-46). Follow-up data (t=52 weeks) were collected 6 weeks 












































Figure S2. Effect of albendazole treatment on HOMA-IR, BMI, Total IgE and Eosinophil count stratified by the 
number of helminth  species carried by infected subjects at baseline as detected by PCR. Effect of albendazole 
treatment on (A) HOMA-IR (n= 1433), (B) BMI (n= 1464), (C) Total IgE (n=1430), and Eosinophil count (n=1422) stratified by 
the number of helminth species infecting subjects at baseline (t=0), as detected by PCR. The estimated treatment effects 
are displayed with corresponding 95% confidence interval. Circle= infected with at least one helminth species, square= no 
infection, triangle= infected with one helminth species, inverse triangle= infected with more than one helminth species. 
Abbreviations: HOMA-IR=Homeostatic Model Assessment for Insulin Resistance, BMI=Body Mass Index, IgE= 
Immunoglobulin E. 
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figure s2. Effect of albendazole treatment on Homa-ir, Bmi, Total igE and Eosinophil count 
stratified by the number of helminth  species carried by infected subjects at baseline as 
detected by pcr. Effect of albendazole treatment on (A) HOMA-IR (n= 1433), (B) BMI (n= 1464), 
(C) Total IgE (n=1430), and Eosinophil count (n=1422) stratified by the number of helminth species 
infecting subjects at baseline (t=0), as detected by PCR. The estimated treatment effects are 
displayed with corresponding 95% confidence interval. Circle= infected with at least one helminth 
species, square= no infection, triangle= infected with one helminth species, inverse triangle= 
infected with more than one helminth species. Abbreviations: HOMA-IR=Homeostatic Model 






































Table s1. summary of subjects lost to follow-up
died moved refused other reasons
Total lost to 
follow Up



































































*% was calculated from all subjects in each treatment arm (placebo n=872, albendazole n=797
Abbreviations: Pla, Placebo; Alb, Albendazole















Negative 396 (66.7) 385 (70.0) 420 (70.7) 527 (95.8)
Low 98 (16.5) 88 (16) 92 (15.5) 18 (3.3)
Moderate 67 (11.3) 58 (10.5) 62 (10.4) 5 (0.9)
High 33 (5.5) 19 (3.5) 20 (3.4) 0 (0.0)
A. lumbricoides
n (%)
Negative 484 (81.5) 462 (84.0) 517 (87.0) 543 (98.7)
Low 26 (4.4) 14 (2.5) 19 (3.2) 1 (0.2)
Moderate 47 (7.9) 43 (7.8) 32 (5.4) 4 (0.7)
High 37 (6.2) 31 (5.6) 26 (4.4) 2 (0.4)
T. trichiura
n (%)
Negative 436 (73.4) 400 (72.7) 460 (77.4) 505 (91.8)
Low 45 (7.6) 49 (8.9) 40 (6.7) 23 (4.2)
Moderate 80 (13.5) 71 (12.9) 63 (10.6) 19 (3.5)
High 33 (5.5) 30 (5.5) 31 (5.2) 3 (0.5)
S. stercoralis
n (%)
Negative 588 (99.0) 547 (99.5) 589 (99.1) 550 (100.0)
Low 3 (0.5) 1 (0.2) 3 (0.5) 0 (0.0)
Moderate 2 (0.3) 1 (0.2) 1 (0.2) 0 (0.0)
High 1 (0.2) 1 (0.2) 1 (0.2) 0 (0.0)
*Ct value of 50 indicates no infection (negative). Ct values <50 were further grouped into 3 categories: Ct<30, 






































Table s3. pathway analysis of the treatment effect on insulin resistance in helminth-infected 
subjects as detected by microscopy
model Estimated Treatment Effect (95%ci), p value
Unadjusted 0.031 (0.004 – 0.059), p=0.04
Adjusted for BMI changes 0.025 (-0.001 – 0.051), p=0.10
Adjusted for total IgE changes 0.030 (0.002 – 0.057), p=0.06
Adjusted for eosinophil count changes 0.026 (-0.002 – 0.053), p=0.13
Adjusted for BMI and eosinophil changes 0.020 (-0.007 – 0.046), p=0.23
Abbreviations: BMI=Body Mass Index, IgE= Immunoglobulin E.
Table s4.a. comparison of baseline infection intensity in subjects infected with single and 
multiple helminth species as detected by pcr
Helminth species
single (n=491)
[ct value, mean (sd)]
multiple (n=296)
[ct value, mean (sd)]
mean differences (95%ci), 
p value*
Hookworm 35.9 (4.0), n=259 34.3 (4.4), n=226 -1.6 (-2.3 – -0.8), p<0.0001
A.lumbricoides 32.9 (3.2), n=75 31.0 (3.7), n=179 -1.9 (-2.9 – -0.9), p<0.0001
T.trichiura 33.7 (2.9), n=156 32.3 (3.3) n=247 -1.4 (-2.0 – -0.8), p<0.0001
This analysis was conducted in subjects analyzed in figure S1. Infection intensity was assessed using Ct values of 
PCR, which represent the amount of DNA in the stool sample. The lower the Ct value, the higher the amount of 
DNA. Number of subjects with S.stercoralis was very low (one within the single infection group and nine within 
the multiple infection group). *Independent t-test.
Table s4.B. comparison of baseline infection intensity in subjects infected with single and 
multiple helminth species as detected by microscopy
Helminth species
single (n=334)
[epg, median (iQr), n]
multiple (n=180)
[epg, median (iQr), n] p value*
Hookworm 96 (48 – 267), n=108 138 (72 – 474), n=108 0.087
A·lumbricoides 360 (72 – 1596), n=103 1980 (432 – 6264), n=143 <0.001
T·trichiura 36 (12 – 120), n=123 84 (36 – 261), n=152 <0.001
This analysis was conducted in subjects analyzed in figure 3. Infection intensity was assessed using the number 
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aims/hypothesis: We aimed to assess the role of adipokines in mediating 
the effect of helminths on insulin resistance. We hypothesized that the 
increase in IR after anthelmintic treatment in helminth-infected subjects 
is mediated by a shift in leptin to adiponectin ratio driving a more pro-
inflammatory state.
methods: Serum samples were obtained from a randomized-controlled trial 
of anthelmintic treatment in an area endemic for soil-transmitted helminths 
(STH), Flores Island, Indonesia. All subjects in the study area received 
albendazole or matching placebo for three consecutive days. This three-
monthly treatment regimen was given for four rounds. We measured leptin, 
adiponectin, and resistin changes in those >16 years old. STH infections were 
assessed by microscopy and PCR.
results: In STH-infected subjects, anthelmintic treatment significantly 
increased the ratio of leptin to adiponectin [treatment effect factor (95% 
CI), p-value for interaction: 1.20 (1.06 – 1.35), p=0.010], which largely 
stemmed from a significant reduction in adiponectin [0.91 (0.85 – 0.98), 
p=0.020] and a trend for an increase in leptin level [1.10 (1.00 – 1.21)], 
p=0.119]. No significant effect on resistin level was observed. This increase 
in leptin to adiponectin ratio seemed to contribute to the observed effect 
of deworming on increased IR as adjustment for leptin to adiponectin ratio 
attenuated the effect on IR from 1.07 (1.01 – 1.14, p=0.023) to 1.05 (0.99 – 1.11, 
p=0.075).
conclusions: Anthelmintic treatment in STH-infected subjects increases 
leptin to adiponectin ratio which may in small part contribute to the modest 
increase in IR. Further studies will be needed to assess the effect of the 
changes in adipokine levels on the host immune response and metabolism.
Keywords: Helminths. Adipokines. Leptin. Adiponectin. Leptin to 
adiponectin ratio. Insulin resistance
abbreviations: AT: adipose tissue, L/A: leptin to adiponectin, STH: soil-



































Emerging evidence suggests that helminths might confer protection against the 
development of type 2 diabetes (T2D),[1-5] presumably by modulating the host 
immune responses.[6-8] Thus, in addition to the more established risk factors, 
such as sedentary lifestyle and high-energy foods, current deworming programs 
in parallel with rapid socioeconomic development might potentially contribute 
to the development of T2D in many low and middle-income countries.[6] In line 
with this, we have recently reported that removal of helminth infections increases 
insulin resistance (IR),[9] which is mainly mediated by the increase in adiposity,[9] 
suggesting a central role of adipose tissue (AT).[10-13] 
Human AT secretes various adipokines, most notably leptin and adiponectin, 
affecting metabolic homeostasis and immune regulation.[14] Leptin and 
adiponectin have been consistently shown to be positively and negatively 
associated with IR, respectively.[14] Whereas leptin promotes pro-inflammatory 
immune responses and inhibits the proliferation of regulatory T-cells, adiponectin 
induces the secretion of anti-inflammatory cytokines.[15] The imbalance between 
those two adipokines, leptin to adiponectin (L/A) ratio, has been reported to be 
associated with pro-inflammatory conditions and IR.[16, 17] 
Assessment of adipokines might provide a valuable insight into the role of human 
AT in mediating the helminths effect on metabolic homeostasis. To our knowledge, 
no studies have been published so far on the association between helminth 
infections and adipokines, except for resistin.[18] Therefore, we measured leptin, 
adiponectin, and resistin in serum samples obtained from a randomized-controlled 
trial of anthelmintic treatment in an area endemic for soil-transmitted helminth 
(STH).[19] We hypothesized that the increase in IR after anthelmintic treatment 
in helminth-infected subjects might be mediated by a shift in L/A ratio towards a 
more pro-inflammatory state.
mETHods
This present study is part of a household-based cluster-randomized double-
blind placebo-controlled anthelmintic trial (The Sugarspin study), conducted 
in Nangapanda, Flores, an endemic area for soil-transmitted helminth (STH).
[19] The primary outcome of the Sugarspin study is changes in insulin resistance 
(IR), as assessed using the homeostatic model assessment of IR (HOMA-IR), after 


































consent was obtained from all participants. The study was approved by the 
ethics committee of Faculty of Medicine, Universitas Indonesia (FKUI) (ref: 549/
H2·F1/ETIK/2013), and filed by the ethics committee of Leiden University Medical 
Center (LUMC). The trial is registered as a clinical trial (http://www.isrctn.com/
ISRCTN75636394).
The population was randomised by blocks at household level. After randomisation, 
all subjects in the study area, except children <2 years old and pregnant women, 
received a single tablet of albendazole (400mg) or matching placebo for three 
consecutive days with direct supervision. This three-monthly treatment regimen 
was given for four rounds. All measurements and sample collections were 
performed at baseline and 6 weeks after the end of the fourth treatment round 
(follow-up).[19] All subjects without sufficient sera samples, and/or incomplete 
data on body mass index, and soil-transmitted helminth (STH) infection status at 
baseline were excluded from the present study. Subjects receiving active treatment 
for diabetes were also excluded from analysis.
All subjects ≥16 years old were invited to undergo clinical measurements and 
blood drawing after an overnight fast.[19] Body weight and height were measured, 
and body mass index (BMI) was calculated as weight (kg) divided by square of 
height (m). Adipokines (leptin, adiponectin and resistin) were measured by ELISA 
using commercial reagents (DuoSet ELISA R&D System Europe Ltd, Abingdon, 
UK), according to the manufacturer’s protocol. Leptin to adiponectin (L/A) ratio 
was calculated by L/A= leptin level (ng/ml) / adiponectin level (ug/ml).[17] Soil-
transmitted helminth infection status was assessed using both microscopy (Kato 
Katz) and PCR, which was further stratified by the number of species a subject was 
infected with at baseline (no infection, single infection, multiple infection).[9] 
statistical analysis
Leptin, adiponectin, L/A ratio, and resistin were log-transformed (log10) for analysis 
and summarized as geometric mean [95% confidence interval (CI)]. The effect of 
anthelmintic treatment on adipokine was assessed using mixed models to account for 
the correlation within households, as described previously.[9] The treatment effect 
estimates were the regression coefficient obtained from mixed models (β) indicating 
changes in log10 (leptin, adiponectin, L/A ratio, resistin) of subjects using albendazole 
compared to placebo. The treatment effect factors (10β) are multiplicative instead 


































variable (leptin, adiponectin, resistin, L/A ratio), in comparison to the placebo. All 
models were fitted using the lme4 package (R software).
rEsUlTs
At baseline, the prevalence of STH infection was 42.0% (503/1195) and 54.1% 
(760/1405), as assessed by microscopy and PCR respectively. Serum leptin, 
adiponectin, L/A ratio, and resistin levels were similar in both treatment arms 
(Table 1). The consort diagram of the present study is shown in figure s1. 
Similar to the main study, anthelmintic treatment significantly reduced the 
prevalence of STH infections, as assessed by microscopy or PCR (Table s1). In 
comparison to placebo, albendazole treatment had no effect on adipokine 
levels in subjects without STH infections (figure 1a). In STH-infected subjects, as 
assessed by microscopy, albendazole treatment increased L/A ratio [treatment 
effect factor (95% CI), p-value for interaction: 1.20 (1.06 – 1.35), p=0.010], which 
was mostly derived from a significant reduction in adiponectin level [0.91 (0.85 – 
0.98), p=0.020] and a trend for an increase in leptin level [1.10 (1.00 – 1.21)], p=0.119] 
(figure 1B). No significant treatment effect on resistin level was observed [1.00 
(0.94 – 1.05), p=0.363] (figure 1B). 





Age (in years, mean, SD) 41.9 (15.4) 42.6 (15.5)
Sex (female %, n/N) 62.0 (500/807) 59.9 (449/750)
Body Mass Index (kg/m2, mean, SD) 22.5 (4.0) 22.5 (4.0)
Leptin to adiponectin ratio [geomean (95% CI)] 1.38 (1.25 – 1.53) 1.35 (1.21 – 1.51)
Leptin (ng/ml) [geomean (95% CI)] 7.1 (6.5 – 7.7) 6.7 (6.1 – 7.4)
Adiponectin (ug/ml) [geomean (95% CI)] 5.1 (4.9 – 5.4) 5.0 (4.7 – 5.3)
Resistin (ng/ml) [geomean (95% CI)] 15.6 (15.0 – 16.2) 15.7 (15.1 – 16.4)
Helminth-infected by microscopy (%, n/N)
43.5 (270/620) 40.5 (233/575)
- Single species 28.2 (175/620) 26.4 (152/575)
- Multiple species 15.3 (95/620) 14.1 (81/575)
Helminth-infected by PCR (%, n/N) 53.8 (392/729) 54.4 (368/676)
- Single species 31.7 (231/729) 35.2 (238/676)
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Pathway analysis showed that adjustment for changes in BMI partly attenuated 
the treatment effect on adiponectin level [to 0.92 (0.86 – 0.99), p=0.030] and L/A 
ratio [to 1.13 (1.02 – 1.26), p=0.040]. Analysis of the Sugarspin trial primary outcome 
revealed that the increased IR after anthelmintic treatment in infected subjects 
might be due to an increased BMI and a reduced eosinophil counts.[9] Therefore 
we also assessed whether the increase in L/A ratio contributes to the increased 
IR after treatment in helminth-infected subjects. This analysis showed that 
adjustment for changes in L/A ratio, attenuated the treatment effect on IR from 
1.07 (1.01 – 1.14, p=0.023) to 1.05 (0.99 – 1.11, p=0.075), even more than adjustment 
for changes in BMI [to 1.06 (1.00 – 1.12), p=0.048].
When light infections were also considered by using PCR, albendazole treatment did 
not significantly increase L/A ratio [1.10 (1.00 – 1.22), p=0.31], despite a significantly 
reduced adiponectin level [0.94 (0.88 – 0.99), p=0.048].  No significant treatment 
effect was observed on the level of leptin, nor resistin (figure s2). Next, we further 
stratified STH-infected subjects based on the number of STH species a subject was 
infected with at baseline. In subjects with multiple STH infections, albendazole 
significantly increased L/A ratio [1.25 (1.06 – 1.48), p=0.041] which derived from 
a significant reduction in adiponectin level [0.88 (0.80 – 0.97), p=0.013] and a 
non-significant increase in leptin level [1.10 (0.97 – 1.25), p=0.47]. (figure s3) 
Using microscopy, a more pronounced reduction in adiponectin [0.88 (0.78 – 
0.99), p=0.049] was observed in subjects infected with multiple STH species. The 
treatment effect on L/A ratio [1.18 (0.96 – 1.45), p=0.157] and leptin level [1.04 (0.89 
- 1.22), p=0.71] in subjects infected with multiple species did not reach statistical 
significance (figure s4). 
discUssion 
Our study is the first to report the effect of anthelmintic treatment on serum 
adipokine levels. In STH-infected subjects, treatment significantly increased L/A 
ratio, which has been reported to be associated with low-grade inflammation [16] 
and IR.[16, 17] The increased L/A ratio was derived by the significant reduction 
in adiponectin level, and to a lesser extent, a trend of increase in leptin level. As 
adiponectin induces the secretion of anti-inflammatory cytokines,[15] while leptin 
increases Th1, suppresses Th2, and can act as a negative signal for the proliferation 
of human T regulatory cells [20], these changes may reverse the helminth-
associated type 2 and regulatory immune responses, and presumably contribute to 


































the treatment-associated increase in IR, observed in the main trial,[9] even more 
than adjustment for increase in BMI. This suggests that adipokines play a relatively 
more important role than the adiposity in the mediation of helminth-associated 
beneficial effect on IR.
Using PCR, a more sensitive method, able to detect non-clinically relevant STH 
infections, the treatment effects were less in magnitude, as it significantly reduced 
adiponectin level only, but to a lesser extent. In line with this, in subjects with multiple 
STH infections, associated with a higher infection intensity,[9] treatment resulted in 
more pronounced effects, namely a significant reduction in adiponectin level, a trend 
for increase in leptin level, as well as a significant increase in L/A ratio. Except for the 
effect on adiponectin, these pronounced treatment effects were not observed when 
infection was assessed by microscopy, which might be due to the lower number of 
subjects who were found to be infected with multiple species, when using microscopy.
Despite having an ideal study design to study the causal relationship between 
helminth infections and adipokine levels, and to assess the contribution of 
adipokine levels to the increased IR after anthelmintic treatment, our study would 
have been more complete if we would have assessed food intake, appetite, and 
physical activity. In addition, measurements of  other hormones that influence 
metabolism, such as ghrelin and cortisol, as well as analysis of AT biopsies and gut 
microbiome, could provide a more complete overview on how helminths may 
modulate human metabolism. 
In conclusion, anthelmintic treatment in STH-infected subjects increases L/A 
ratio which may in small part contribute to the increased IR. Further studies will 
be needed to assess the effect of these changes in adipokine levels on the host 
metabolism and modulation of the host immune responses.
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Figure S1. Consort Diagram. Baseline data (t=0) were collected during the first 8 weeks before the start of the 
drug administration. $Single dose of albendazole or matching placebo was given for three consecutive days to 
all household members, except children below 2 years of age and pregnant women. *Other reasons of lost to 
follow-up were harvesting crops, working on funeral ceremonies, severely ill, hospitalized, nursing mother. HH: 
Household, FU: Follow Up. 
  
figure s1. consort diagram. Baseline data (t=0) were collected during the first 8 weeks before 
the start of the drug administration. $Single dose of albendazole or matching placebo was given 
for three consecutive days to all household members, except children below 2 years of age and 
pregnant women. *Other reas ns of lost to follow-up wer  harvesting crops, worki  on funeral 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table s1. Effect of anthelmintic Treatment on soil-transmitted Helminth prevalence
method
placebo albendazole
p-value*Baseline follow-up Baseline follow-up
Microscopy (%, n/N) 43.5% (270/620) 26.8% (166/497) 40.5% (233/575) 5.2% (24/466) <0.0001
PCR (%, n/N) 53.8% (392/729) 45.0% (250/555) 54.4% (368/676) 10.4% (55/529) <0.0001
*Analyzed using logistic model (lme4 package R software) with random household effects and random subject effects
Table s2. pathway analysis on the role of leptin to adiponectin ratio in the increased insulin 
resistance after anthelmintic treatment
crude l/a ratio Bmi l/a ratio + Bmi
HOMA-IR* 1.07 (1.01 – 1.14)
p=0.023
1.05 (0.99 – 1.11)
p=0.075
1.06 (1.00 – 1.12)
p=0.048
1.05 (0.99 – 1.11)
p=0.075
*Analyses were performed using linear mixed model in unadjusted model (crude) and adjusted for leptin to 
adiponectin (L/A) ratio, BMI, or both.

PART II
What are the differences in metabolic 




impact of rural-urban environment 
on metabolic profile and response 
to a 5-day high-fat diet
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Epidemiological studies have indicated that rural living might be protective 
against type 2 diabetes development. We compared the metabolic profile 
and response to a short-term high-fat high-calorie diet (HFD) of people with 
the same genetic background living in an urban and rural area of Indonesia. 
First, we recruited 154 Floresian male subjects (18-65 years old), of whom 
105 lived in a rural area (Flores) and 49 had migrated and lived in urban area 
(Jakarta) for more than 1 year. The urban group had significantly higher 
whole-body insulin resistance (IR), as assessed by homeostatic-model-
assessment of IR (HOMA-IR), [mean difference (95%CI), p-value: 0.10 (0.02 
– 0.17), p=0.010]. Next, we recruited 17 urban and 17 rural age-and-BMI-
matched healthy-young-male volunteers for a 5-day HFD challenge. The 
HOMA-IR increased in both groups similarly [-0.77 (-2.03 - 0.49), p=0.223]. 
Neither rural living nor factors associated with rural living such as current 
helminth infection and total IgE were associated with protection against 






































The prevalence of obesity and type 2 diabetes (T2D) is increasing worldwide, 
especially in low and middle-income countries (LMIC) that are currently facing rapid 
rate of urbanization.[1, 2] Rural-to-urban migration has indeed been shown to be 
associated with increased obesity and other cardiovascular (CV) risk factors, such 
as dyslipidemia and hypertension,[3-11] suggesting that living in rural environment 
might be protective against T2D development.
In addition to changes towards a sedentary lifestyle and increased dietary fat 
intake, migration to an urban environment is also associated with a reduction 
exposure to microorganism and parasites, such as helminth infections, which are 
still endemic in many rural areas of LMIC.[12] There is data suggesting that helminth 
infections might confer a protection against the development of obesity and 
T2D,[13-16] presumably by promoting type-2 and regulatory immune responses 
and subsequent reduction in systemic inflammation.[17-19] However, it is worth 
mentioning that the relative contribution of helminth infections in comparison 
to the more established factors such as a sedentary lifestyle and diet remains to 
be clarified. 
An increase in dietary fat intake, commonly observed upon rural-to-urban 
migration,[7, 20] has been reported to be associated with impaired insulin resistance 
(IR) and glucose homeostasis.[21] Mice on high-fat diet (HFD) have provided 
models to study obesity and the development of IR.[22, 23] Similarly, in humans, 
short-term HFD has been utilized to study the susceptibility to the development of 
IR,[24-28]. Using this model, it has been possible to show how risk of IR is dependent 
on ethnicity.[25, 28] Short-term HFD has also been shown to induce organ-specific 
and systemic inflammation as evidenced by the increase in plasma cholesteryl 
ester transfer protein (CETP) level,[24, 29] which is predominantly produced by 
Kupffer cells (KC),[30] as well as in plasma C-reactive protein (CRP) level [24]. 
Taken together, the chronic increase of energy rich diet, in addition to a more 
sedentary lifestyle, among people who migrate from a rural to urban areas,[20] 
might lead to the development of IR and T2D. However, there is still incomplete 
insight into the pathophysiology of the development of IR and T2D in rural-to-
urban migration. In addition, there has been no study comparing the metabolic 
response towards a short-term HFD in terms of changes in glucose homeostasis 





































As some metabolic differences between subjects living in rural and urban area can 
be due to genetic differences, this study compared the metabolic profile between 
individuals with the same genetic background living in urban and rural areas, and 
examined their metabolic and inflammatory response to a 5-day high-fat high-
calorie (HFD) diet.  Furthermore, as rural areas often go hand in hand with helminth 
infections and associated IgE responses, we aimed to assess their contribution 
to metabolic profile. We hypothesized that individuals living in rural areas, in 
comparison to those living in urban areas, will have a better metabolic profile 
and will be relatively more protected from the induction of IR and inflammation 
by the HFD.
mETHods
study design and population
The present study consisted of a cross-sectional and an interventional study. 
The cross-sectional study was performed in an urban (Jakarta) and a rural area 
(Nangapanda, Ende, Flores island) in Indonesia. We recruited 49 males (18-65 years 
old) with Floresian ethnical background who had migrated from Flores island and 
lived in Jakarta for more than 1 year (urban group). As their rural counterparts, 
we recruited 105 Floresian males with a similar age range, randomly selected from 
three villages in Nangapanda with age stratification, as described previously.[31] 
For the HFD intervention study, 17 from urban and 17 from rural area, age-and-
BMI-matched healthy young male volunteers (18-40 years old) were recruited via 
local healthcare workers who informed their community, in both Nangapanda 
and Jakarta, of the study. BMI-matching was performed to assess whether the 
difference between urban and rural in term of past or current exposure to STH 
infections affect the HFD-associated increase in IR, independent of adiposity. 
Exclusion criteria were T2D, recent body weight changes, intake of medication 
that could affect inflammation or IR. 
The study was approved by the Medical Ethical Committee of the Faculty of 
Medicine, Universitas Indonesia (556/H2.F1/ETIK/2014) and performed in 
accordance with the principles of the revised Declaration of Helsinki. All volunteers 






































In the cross-sectional study, we invited all subjects to come to the Field Study Centre 
(FSC) in both rural and urban area to undergo clinical measurements and blood 
sample collections. Stool samples were also collected. All clinical measurements and 
blood sample collections were performed after an overnight fast. Anthropometric 
measurements of body weight, height, and waist circumference were performed. 
BMI was calculated as weight in kg divided by square of height in meter. 
After collection of fasting blood samples, we performed an oral glucose tolerance 
test (OGTT), in which blood glucose levels were re-measured 2 hours after 
subjects were given 75g glucose dissolved in 200 mL of water (2h-BG). In this cross 
sectional study, we calculated HOMA-IR (homeostatic model assessment of insulin 
resistance), a well-validated measure of whole-body IR in humans (HOMA-IR = 
fasting serum insulin (mU/L)  x fasting glucose (mmol/L) / 22.5)[32], as our primary 
outcome. We also measured HbA1c, fasting blood glucose (FBG), fasting insulin, 
2h-BG, BMI, waist circumference, adiponectin, leptin, high-sensitive C-reactive 
protein (hsCRP), total IgE, and prevalence of soil-transmitted helminths (STH) as 
our secondary outcomes. 
Intervention Study
Subjects were examined before and after a 5-day HFD intervention, consisting of 
the subject’s regular diet supplemented with 375 mL cream (Greenfields™ Whipping 
Cream, Greenfields Indonesia Ltd, Jakarta, Indonesia) per day [1,500 kcal/day, 83% 
fat (60% saturated fat)]. After baseline measurements, each subject received three 
bottles of 125 mL cream per day for five consecutive days. Subjects were instructed 
to continue their regular diet, and to consume one bottle of cream after each meal 
(3 meals per day) to make sure they could adhere to their regular dietary habits. 
Subjects were asked to keep a food diary before and during the HFD intervention 
to estimate normal dietary intake and to check for compliance and compensatory 
behavior. Dietary assessment, using a 24 hours food recall, was performed by a 
trained dietician. Compliance was further assessed by interviewing the subject 
and collecting the bottles every day. During the study, subjects were asked not to 
change lifestyle habits. Measurements of clinical parameters and blood drawing 
were done on the day before starting the HFD intervention (D-0) and one day 





































In this intervention study, we had HOMA-IR as our primary outcome. As our 
secondary outcomes, we measured adipose-IR index, a measure of adipose tissue 
IR, which was calculated as the product of the fasting serum free fatty acid (FFA) 
and insulin (Adipose-IR index = FFA[mM] x Insulin [pM]).[33, 34] In addition, we 
also measured hsCRP, CETP, and lipid levels [total cholesterol (TC), high-density 
lipoprotein cholesterol (HDL-C), triglycerides (TG), low-density lipoprotein 
cholesterol (LDL-C)]. Due to limited amount of sera after intervention, adiponectin 
and leptin level were measured only at baseline. All others measurements for the 
interventional study were performed pairwise (before and after intervention).
laboratory measurements
Fasting blood glucose and 2h-post-load glucose were measured in capillary blood 
using Breeze®2 glucose meters (Bayer Health Care LLC, Basel, Switzerland) in the 
FSC. All sera, plasma and whole blood samples from rural area were frozen at −20°C 
in the FSC, and subsequently shipped and stored at −80°C in Faculty of Medicine 
Universitas Indonesia (FKUI), Jakarta, Indonesia and Leiden University Medical 
Centre (LUMC), Leiden, The Netherlands. All sera, plasma and whole blood samples 
from urban area were directly transported from FSC (Jakarta) to be stored at −80°C 
in FKUI, and subsequently shipped and stored at -80°C at LUMC.
Serum insulin concentrations were determined by a solid-phase, enzyme-
labeled chemiluminescent immunometric assay, while HbA1c was measured 
using a cation-exchange chromatography (IC)-based high performance liquid 
chromatogtaphy (HPLC) assay. A latex-enhanced immunoturbidimetric method 
was used to measure hsCRP. Assays of TC, HDL-C, and TG were based on enzymatic 
colorimetric methods. These measurements have been described previously.[16] 
To convert from mmol/L to mg/dL, we multiplied the TC, HDL-C, and LDL-C level 
by factor of 38.67, while for TG levels we multiplied by 88.57.
Plasma CETP levels were measured with enzyme-linked immunosorbent assays 
(ELISA) kits according to the manufacturer’s instructions (DAIICHI CETP ELISA, 
Daiichi, Tokyo, Japan). FFA were measured using ELISA kits according to the 
manufacturer’s instructions (abcam ab 65341 FFA Quantification Assay Kit, 
Cambridge, UK).  Adiponectin and leptin were also measured by using ELISA 
commercial reagents (DuoSet ELISA R&D System Europe Ltd, Abingdon, UK). The 
levels of total IgE, an important determinant of total IgE levels,[35] were measured 





































(Necator americanus, Ancylostoma duodenale), Ascaris lumbricoides, Trichuris 
trichiura, Strongyloides stercoralis] was assessed using PCR as described in detail 
elsewhere [36, 37] 
statistical analysis
Normally distributed continuous variables were summarized as mean and standard 
deviation [mean (SD)], while non-normally distributed data were summarized as 
geometric mean and its 95% confidence interval [geomean (95% CI)].  In the cross-
sectional study, sample size was calculated to aim at a difference in HOMA-IR 
between urban and rural group of 0.5. The SD of HOMA-IR from previous study 
was 0.84.[14] We used a significance level of 5% and a power of 80%, thus we 
needed at least 45 subjects for each group. For the interventional study, sample 
size was calculated to aim at a difference in changes of HOMA-IR between urban 
and rural group of 0.70. The SD of the HOMA-IR changes after HFD intervention 
from previous study was 0.68.[25] We used a significance level of 5% and a power 
of 80%, thus we needed at least 15 subjects per group or 30 subjects in total. Next, 
to assess STH effect on the metabolic response upon HFD intervention we used 
similar calculation, aiming at having at least 15 subjects per group.
figure 1. conceptual framework.  In the cross-sectional study (A), we assessed whether the 
differences in past or current exposure to helminths contribute to the difference in insulin resistance 
(IR) between subjects living in urban and rural area, and whether the observed difference in IR is 
independent from adiposity. In the high-fat diet (HFD) study (B), first, we assessed whether past 
or current exposure to helminths protect against the HFD-associated increase in IR, independent 
of adiposity. Next, we also assessed whether the presence of current helminth infection protect 
against the HFD-associated increase in IR. *Past and current exposure to helminths was assessed 
by measuring serum total IgE level, a general marker for Th2 responses, commonly induced by soil-
transmitted helminth (STH). Current exposure to helminths was assessed using stool PCR. #Other 





































The original plan for the linear regressions was based on a conceptual framework 
(figure 1) of the proposed causal pathways. In the cross-sectional study (A), we 
assessed whether the difference between urban and rural subjects, in term of past 
or current exposure to STH, by using total IgE level as a proxy, contributes to the 
difference in insulin resistance (IR) between subjects living in urban and rural area, 
and whether this difference in IR is independent from adiposity. Next, we further 
stratified the urban and rural group based on their STH infection status. However, 
as the number of urban subjects with STH infections was very low and therefore 
was excluded from analysis, eventually we had three groups: rural subjects with STH 
infections, rural subjects without STH infections, and urban subjects without STH 
infections. We calculated variance inflation factors (VIFs) to check multicollinearity 
in our regression models and VIF values below 4 were considered appropriate. 
Due to multicollinearity between BMI and WC, we used WC as clinical marker for 
adiposity. In addition, we also assessed the association between length of stay 
in urban area and metabolic profiles (IR, adiposity, and leptin) among subjects 
living in urban area using age-adjusted linear regression model. Analyses were 
performed using IBM Statistics 23.
In the HDF intervention study (B), first, we assessed whether the difference between 
urban and rural in term of past or current exposure to STH infections affect the 
HFD-associated increase in IR, independent of adiposity, by matching both groups 
for BMI. To compare the parameter before and after the HFD intervention for each 
group, whenever appropriate, paired t-test or Wilcoxon-signed ranked test was 
performed. A mixed model was applied to assess mean differences before and after 
intervention between group. Groups were modelled as fixed effects, and to model 
correlation within subjects, random-specific intercept was used. Next, among 
subjects living in rural area, similar model was used to further assess whether the 
presence of current STH infections protect against the HFD-associated increase in 
IR. The mixed model analysis was performed using R software (lme4).
rEsUlTs
The metabolic profile of rural and urban study participants  
The mean length of stay of urban subjects in Jakarta was 20.7 (range: 1 - 40) years. 
The differences in metabolic profile between subjects living in rural and urban 
are summarized in Table 1. Urban subjects had a significantly higher HOMA-IR 





































p=0.010]. Similarly, other metabolic parameters, such as 2h-blood glucose, HbA1c, 
BMI, waist circumference, and leptin level were significantly higher in urban 
subjects (Table 1). Interestingly, independent of age, increasing length of stay in 
urban area (in years) was positively associated with increasing BMI [estimate (95% 
CI), 0.152 (0.036 – 0.269) kg/m2, p=0.012, figure 2a], waist circumference [0.449 
(0.135 – 0.762) cm, p=0.006, figure 2B] and to a lesser extent with leptin [0.013 
(-0.001 – 0.027), p=0.068], but not HOMA-IR [0.005 (-0.003 – 0.013), p=0.182].
The prevalence of STH was significantly lower in the urban compared to rural 
subjects [5% (2/42) vs 57% (52/92), respectively, p<0.0001]. Similarly, the levels of 
total IgE, often driven by STH infections,[35] were lower in the urban compared 
to rural subjects (168 (105 – 271) IU/mL vs 931 (702 – 1.235) IU/mL, respectively, 
p<0.0001) (Table 1).  






Duration in urban (in years) 20.7 (1.0-40.0) -
Age (in years) 39.3 (13.5) 44.5 (12.2)*
HOMA-IR 1.45 (1.06 – 1.90) 0.96 (0.80 – 1.13)*
Fasting Insulin (mU/L) 4.9 (3.8 – 6.4) 3.1 (2.5 – 3.8)**
Fasting Blood Glucose (mmol/L) 5.7 (1.4) 5.4 (0.9)
2h-Blood Glucose (mmol/L) 7.7 (3.2) 5.9 (1.9)**
HbA1c# (mmol/L) 37.9 (14.3) 32.3 (6.6)*
HbA1c# (%) 5.6 (1.3) 5.1 (0.6)*
Body Mass Index (kg/m2) 24.3 (4.9) 22.7 (4.0)*
Waist Circumference (cm) 84.9 (13.8) 79.3 (11.9)*
Adiponectin (µg/mL) 4.38 (3.31 – 5.78) 3.54 (3.09 – 4.07)
Leptin (ng/mL) 5.62 (3.98 – 7.92) 2.64 (2.06 – 3.38)*
CRP (mg/L) 1.57 (1.17 – 2.05) 1.67 (1.29 – 2.11)
Total IgE (IU/mL) 168 (105 – 271) 931 (702 – 1,235)**
Prevalence of STH (%, n/N) 5 (2/42) 57 (52/92)**
All variables are presented as mean and its standard deviation, however, HOMA-IR, fasting insulin, adiponectin, 
leptin, CRP, and total IgE level are presented as geomean (95%CI) and were log transformed for analysis, while 
duration in urban is presented as mean (range). Analysis for the difference between urban and rural group was 
performed using independent t-test (*p<0.05, **p<0.0001) #Hba1c measurements were available in 42 and 95 of 
urban and rural subjects respectively. Abbreviation: HOMA-IR= the homeostatic model assessment of insulin 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As the number of subjects with current STH infections in urban area was very low 
(n=2), it was not possible to assess the contribution of current STH infections to 
the HOMA-IR difference between urban and rural subjects. Therefore, we used 
total IgE level as a proxy for past and current STH exposures. The age-adjusted 
difference in HOMA-IR between urban and rural subjects was slightly attenuated 
[from estimated mean differences (95% CI), 0.09 (0.02 – 0.17), p=0.0010 to 0.08 
(-0.00 – 0.17), p=0.061] after further adjustment for total IgE level (Table 2). 
Further adjustment for total IgE level also attenuated the age-adjusted difference 
in waist circumference [from 7.2 (2.0 – 11.3), p=0.001 to 4.2 (-0.5 – 8.8), p=0.077] 
and leptin level [from 0.36 (0.18 – 0.55), p<0.0001 to 0.10 (-0.03 – 0.24), p=0.137] 
(Table 2). To assess the contribution of adiposity and leptin in the difference in 
HOMA-IR between urban and rural, adjustment with waist circumference [to 
0.02 (-0.04 – 0.08), p=0.545] or both waist circumference and leptin level [to 
0.01 (-0.06 – 0.07), p=0.774] strongly attenuated the difference in HOMA-IR 
(Table 2).
In addition, we stratified rural and urban subjects based on STH infection status 
into three groups, namely: urban group without STH infections, rural group 
without STH infections, and rural group with STH infections. The highest value of 
HOMA-IR, waist circumference, and leptin was observed in urban group without 
STH infections, followed by rural group without STH infections and the lowest 
among rural group with STH infections (figure s1). The contrast was observed for 
total IgE level (figure s1).
comparison of metabolic responses after a short-term Hfd 
intervention between subjects living in an urban and rural area
Among subjects who were included in the interventional part of the study 
(n=34), we observed no significant differences between the age-and-BMI-
matched urban (n=17) and rural group (n=17) in terms of HOMA-IR, adipose-IR 
index, CRP, and lipid levels at D-0 (Pre HFD). At this time point, serum CETP levels 
were significantly lower in the urban group [1.96 (0.58) µg/mL vs 2.59 (0.64) µg/
mL, in urban and rural group respectively, p=0.006]. Both groups showed a 
good compliance in terms of dietary intervention, all participants consumed all 
the cream provided and maintained their regular diet, resulting in a  mean daily 
calorie intake that was ~60% higher compared to their regular diet, and ~56% of 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Intervention with a 5-day HFD resulted in a significant increase of HOMA-IR in both 
the urban [from 0.78 (0.51 – 1.09) to 1.13 (0.78 – 1.57), p=0.03] and rural group [from 
0.87 (0.59 – 1.21) to 1.69 (1.01 – 2.45), p=0.001] (figure 3.a, Table s1), which was mainly 
driven by the increase in fasting insulin level in both urban [from 4.05 (2.98 – 5.52) 
to 5.59 (4.18 - 7.47), p=0.02] and rural group [4.63 (3.42 – 6.26) to 7.68 (5.70 – 10.34), 
p=0.001] (Table s1). Comparing the changes in IR before and after intervention 
between urban and rural group, we observed no significant differences for either 
HOMA-IR [estimated mean differences (95% CI), -0.77 (-1.95 – 0.41), p=0.21] (figure 
3.a, Table s1) or adipose-IR index [-41.20 (-115.12 – 32.73), p=0.28] (Figure 3.B, Table S1). 
Interestingly, we observed a significant increase in CETP levels after HFD intervention 
in the urban group only [from 1.96 (0.58) to 2.28 (0.63), p=0.004 in urban group 
vs from 2.59 (0.64) to 2.58 (0.72), p=0.93 in rural group) (figure 3.c). Therefore, in 
comparison to the rural group, the increase in CETP level was significantly higher 
in urban group [0.33 (0.06 – 0.60), p=0.02] (figure 3.c, Table  s1). However, as 
indicated above, the CETP levels were already much higher in the rural group at 
D-0 (Pre HFD), even higher than the D-6 (post-HFD) CETP level in the urban group. 
Intervention with HFD also did not significantly increase hsCRP in the two groups 
(Table s1). In terms of HFD effects on lipid levels, whereas we observed no significant 
difference in changes in TC, LDL-C, and TG levels between urban and rural groups, 
the increase in HDL-C after intervention was significantly higher in the urban group 
in comparison to rural group [3.34 (0.19 – 6.50), p=0.04] (Table s1).
The effect of current sTH infections on the metabolic responses 
upon short-term Hfd intervention
Next, due to the very low prevalence of STH infections in the urban group [6% 
(1/17)], the effect of current STH infections on the metabolic response towards a 
short-term HFD intervention was only assessed in the rural group of which 50% 
was positive for STH infection (8/16). Thus, our study was underpowered (power of 
56%) to detect any differences in metabolic responses between STH-infected and 
uninfected subjects. 
Despite a significantly lower baseline body weight in STH-infected subjects [51.1 
(11.0) kg vs 63.3 (10.2) kg, p=0.037], there was no significant difference in the 
magnitude of increase in HOMA-IR in STH-infected and STH-uninfected subjects 
[-1.08 (-3.38 – 1.22), p=0.36] (figure 3.d), adipose-IR [-87.82 (-222.08 – 46.44), 





































intervention in comparison to uninfected subjects. Interestingly, we observed 
a significantly higher increase in LDL-C level [10.49 (1.99 – 18.99), p=0.03] after 
intervention among STH-infected subjects in comparison to STH-uninfected 
subjects (Table S2). However, the LDL-C level were much lower in STH-infected 
group at D-0 in comparison to STH-uninfected group [85.8 (11.9) vs 114.9 (24.7), 
p=0.013], and the LDL-C level at D-6 in STH-infected group [94.5 (10.8)] did not 
reach the LDL-C level in the STH-uninfected group at D-0 (Table s2).
discUssion
Our study showed that, in comparison to individuals living in a rural area, those living 
in an urban area had higher whole-body IR, as assessed by HOMA-IR. This higher 
whole-body IR was mainly mediated by the higher adiposity and leptin levels. To 
a lesser extent, the differences in exposures to STH infection between urban and 
rural individuals, might to a small extent contribute to the differences in whole-
body IR, adiposity or leptin level. Intervention with a short-term HFD increased 
whole-body IR in both the urban and rural group. In comparison to rural group, 
CETP level was lower in the urban group, and HFD intervention induced a stronger 
increase in CETP in this group. The presence of STH infections did not seem to 
have a protective effect on acute induction of IR from short-term HFD, however it 
has to be noted that our study was underpowered to detect an STH effect.
Our study found that the higher whole-body IR in individuals living in urban 
area was mediated by the higher adiposity, as well as a higher leptin level, a pro-
inflammatory adipokine, which has been previously reported to be associated 
with glucose metabolism.[8, 38]  The increase of adiposity and, to a lesser extent, 
leptin level, was positively associated with the duration of time spent in the urban 
environment. This suggests that a higher degree of acculturation in terms of urban 
lifestyle, drifting away from their traditional lifestyle,[11] could lead to a positive 
energy balance,[20] hence increasing adiposity over time. In addition, reduced 
exposures to environmental factors, such as to STH infections, which have been 
shown to have beneficial metabolic effects,[13] partly through the induction of 
type-2 and regulatory immune response,[18, 19] might contribute to the difference 
in whole-body-IR, adiposity,  and leptin level between urban and rural individuals. 
This was supported by our finding that the difference in whole-body IR, adiposity, 
and leptin level between urban and rural individuals was attenuated, but only 
slightly, after adjustment for total IgE level, a general marker for type-2 immune 





































Next, whereas, as expected the overall metabolic profile of individuals living in a 
rural area, in term of adiposity and whole-body IR, was better, in comparison to 
those living in an urban area, in contrast to our hypothesis, a short-term 5-day HFD 
intervention induced a similar increase of IR in both urban and rural individuals. As 
both groups were BMI-matched, these findings suggest that the direct protective 
metabolic effect of a combined past and current environmental exposures to 
helminths,[13] independent of their effect on adiposity, might be relatively weak 
in comparison to the strong induction of IR by the HFD intervention. Indeed, our 
group has recently reported that the increased IR in STH-infected subjects after 
deworming was mainly mediated by the increased adiposity.[16] Thus, adjusting 
for adiposity, in a way, remove the possible main pathway for STH-associated 
protection against the development for IR.
Although our study was underpowered to assess the effect of current STH infection, 
it is possible that the presence of current STH infections might not be sufficient to 
protect against a strong induction of IR by short-term HFD, as in rural subjects, 
the increase in IR after HFD in STH-infected subjects was similar in comparison to 
STH-uninfected subjects. However, it is possible that the HFD intervention in STH-
infected subjects with lower body weight would have a stronger impact than in 
STH-uninfected subjects, masking any protective effects of STH infections.
Interestingly, we observed that the baseline serum CETP level was significantly 
lower in urban subjects. As CETP is mainly produced by KCs, higher CETP level 
may represent an increase in hepatic macrophage (KC) content, hence liver 
inflammation.[30] Also, environmental factors in the rural area, mainly exposure to 
various infectious agents, such as microorganisms and parasites, may explain the 
increased CETP level. For instance, it has been shown that subjects with chronic 
hepatitis C virus infection have elevated serum CETP levels.[39] Supporting this, 
the prevalence of hepatitis in our rural study area was higher than our urban 
study area (4.3% vs 0.8%).[40] However, currently, there are no available data 
connecting macrophage polarization status to CETP level and therefore further 
studies are needed.[41]
In contrast to what is seen  in urban subjects,[24, 29] we found no increase in CETP 
levels in rural subjects after the HFD intervention. It is possible that the lack of an 
increase in CETP level in rural subjects was caused by the CETP levels that were 





































Our results suggest an inflammation-independent mechanism of short-term HFD-
associated induction of IR[23]  there was no significant increase in CRP following 
HFD. Studies on the role of inflammation in HFD-associated induction of IR have 
shown conflicting results. In one study an increase in CRP and expression of M1 
macrophage markers in skeletal muscle was reported,[24] while in another, no 
increase was seen in circulating pro-inflammatory cytokines.[42] 
In terms of lipid levels, while no significant changes in lipid levels were observed 
in rural group, HFD intervention significantly increased HDL-C level in urban 
group. As it has been reported that urban subjects had a higher fat intake than 
rural subjects[20] at baseline and the fact that both groups received the same type 
of HFD intervention, differences in the relative changes of dietary composition 
before and after intervention[43-45] between urban and rural might potentially 
contribute to the difference in HDL-C level changes after intervention. In rural 
group, while no significant changes were observed in STH-uninfected subjects, 
HFD intervention resulted in a significant increase in LDL-C in STH-infected 
subjects, which might be related to the lower baseline LDL-C level and body weight 
in STH-infected subjects.
Our study is the first to compare the metabolic profile between people with the 
same genetic background, living in different environments (urban and rural) and to 
assess the metabolic responses to an intervention with a standardized short-term 
HFD. However, our study has several limitations. Due to the low prevalence of STH 
in urban area, our study could only assess the effect of current STH infections on 
HFD-induced IR in rural subjects. In addition to using a calculated HOMA-IR instead 
of the gold standard glycemic clamp to assess IR, physical activity assessment 
and biopsies on specific metabolic tissues (liver, muscle, adipose tissue) were 
not available. 
In conclusion, in comparison to their rural ethnic counterparts, individuals living 
in an urban area had a higher whole-body IR, which was mainly mediated by their 
higher adiposity. The differences between urban and rural individuals in terms of 
past and current exposures to STH might have a relatively small contribution to 
the difference in whole-body IR. Contrary to our hypothesis, intervention with a 
short-term HFD induced similar increase in IR, in urban and rural individuals and in 
helminth infected and uninfected subjects. However, well-powered larger studies 
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Figure S1. The comparison of metabolic profile of rural and urban subjects stratified by helminth infection 
status. The levels of total IgE, HOMA-IR, waist circumference, and leptin on different group of living area and 
soil-transmitted helminth (STH) infection status are presented as geometric mean and its 95% confidence 
interval, except for waist circumference which are presented as mean (SD). The number of urban subjects with 
helminth infections was very low (2/42) and was not included in this graph. Trend analysis was performed 
between three groups, namely: (1) rural subjects with STH infections [Rural (+)], (2) rural subjects without STH 
infections [Rural (-)], and (3) urban subjects without STH infections [Urban (-)]. Total IgE level was the lowest in 
Urban (-) group and progressively become higher in Rural (-) and Rural (+) groups (A). The contrary was 
observed for HOMA-IR (B), waist circumference (C), leptin level (D). *p<0.05 in unadjusted model, **p<0.05 in 
age-adjusted model, ***p<0.05 in age-waist circumference-adjusted model.  
figure s1. The comparison of metabolic profile of rural and urban subjects stratified by 
helminth infection tatus. The levels of total IgE, HOMA-IR, waist circumference, and leptin on 
different group of living area and soil-transmitted h lminth (STH) infect on status are presented 
as geo etric mean and its 95% onfidence interval, except for waist ircumference which are 
presented as mean (SD). The number of urban subjects with helminth infections was very low (2/42) 
and was not included in this graph. Trend analysis was performed between three groups, namely: 
(1) rural subjects with STH infections [Rural (+)], (2) rural subjects without STH infections [Rural (-)], 
and (3) urban subjects without STH infections [Urban (-)]. Total IgE level was the lowest in Urban 
(-) group and progressively become higher in Rural (-) and Rural (+) groups (a). The contrary was 
observed for HOMA-IR (B), waist circumference (c), leptin level (d). *p<0.05 in unadjusted model, 
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6
sUmmarY of WHaT Was alrEadY KnoWn
•	 The prevalence of obesity and type 2 diabetes is increasing, especially in 
urban areas of LMIC.
•	 Rural to urban migration is associated with increased risk of obesity
•	 In rural area, helminth infections are still highly prevalent, while the 
prevalence of T2D is low
•	 Studies in animal models have shown a protective effect of helminth 
infections on glucose metabolism
•	 Cross sectional studies have shown that past and current chronic helminth 
infections are associated with lower adiposity and insulin resistance.
•	 Recent animal studies reported an important role of adipose tissue in 


















WHaT Was alrEadY KnoWn aBoUT HElminTH 
infEcTions, UrBaniZaTion, and TYpE 2 diaBETEs?
The prevalence of T2D is increasing worldwide, especially in urban areas of LMIC, 
whereby socioeconomic changes leads to increased adiposity and development 
of T2D.[1, 2] In animal models, a protective role for helminth infections on glucose 
metabolism was suggested.[3-8] In most rural areas of LMIC, where helmints are 
still highly prevalent, the prevalence of T2D is low, showing  an inverse ecological 
association between STH and T2D.[9, 10] In line with this, several cross-sectional 
studies from different populations reported on the possible protective metabolic 
effects of past[11, 12] or current helminth infections[13, 14]. Despite the fact that a 
recent meta-analysis confirmed the protective metabolic effects of helminths[15], 
all available evidence from human studies were cross-sectional, thus, no causal 
relation could be drawn.
In general, the prevalence of T2D in rural areas is lower,[2] suggesting that living 
in rural area might give a relative protection against the development of T2D, in 
comparison to living in an urban area. It has been suggested that, in addition to the 
better known changes in diet and lifestyle, reduced biodiversity, commonly seen in 
urban areas, might also play some role in the increasing prevalence of inflammatory 
diseases,[16] including T2D. Furthermore, current deworming programs in many 
LMICs,[17, 18] might also contribute by removing helminth-associated beneficial 
effects,[9] which in turn alleviates helminth-associated induction of type 2 immune 
responses and regulatory network,[19] thus increasing the risk of inflammatory 
disorders, including T2D.[9, 10, 20-22] 
Chronic low grade inflammation seems to be a key characteristic of obesity and 
T2D.[23] Whereas in obesity-associated development of IR, AT inflammation plays 
an important role,[23-26] experimental studies in animal model have shown that 
helminth infections cause changes in AT.[4-7] These changes are not only in terms 
of lowering fat mass, but also involve the immune cell composition in AT, shifting 
towards a more anti-inflammatory milieu, and better glucose homeostasis.[4-7] 
sUmmarY of THE findings
•	 Repeated three-monthly treatment with triple dose of 400mg 
albendazole over 12 months reduced STH prevalence and intensity, thus 
to reach a substantial reduction in STH, a more intensive deworming 
than the current policy is needed.
•	 At community level, 12 months of anthelmintic treatment reduced total 
IgE level and eosinophil count, but did not affect insulin resistance.
•	 In STH-infected subjects, as assessed by microscopy, 12-month 
anthelmintic treatment increased insulin resistance, which was 
mediated by an increase in BMI and leptin to adiponectin ratio (L/A 
ratio), as well as reduction in eosinophil count.
•	 In comparison to those living in rural area, individuals living in urban area 
had higher whole body insulin resistance, which was mainly mediated 
by the higher adiposity and leptin level, which were progressively 
increased with increased duration of time spent in urban area. 
•	 Different environmental factors (including past or current exposure to 



















HoW did oUr sTUdiEs adVancE THE fiEld?
Through designing  a randomized controlled trial (RCT) of anthelmintic treatment 
in a rural area of Indonesia[27], endemic for  STH[28], as detailed in chapter 2, it 
was possible, for the first time, to study the effect of anthelmintic treatment on the 
host metabolic homeostasis. Four rounds of three-monthly albendazole treatment 
given for three consecutive days lead to a significant reduction in infection intensity 
and prevalence but not elimination of STH.[29] Our triple doses of albendazole 
treatment regimen resulted in lower prevalence of  helminth compared to  single 
dose albendazole treatment previously given in the same study area.[28] Although 
not a major questions in our study, our data are important for the global deworming 
programs, as they indicate that the current annual single dose treatment[18] is 
unlikely to have an impact on the control, and in particular the elimination of STH. 
The issue of re infection needs to be considered,[30, 31] and in addition to intensive 
treatment, interruption of transmission by decontaminating the environment[32] 
will be essential for any global impact to be achieved. 
Besides reduction in prevalence and intensity of STH infections, anthelmintic 
treatment also led to a significant reduction of Th2 responses at the community 
level, as measured by total IgE and eosinophil counts[29], which is in line with a 
previous report in Ecuador[33]. However, it did not affect insulin resistance nor 
any other metabolic parameter at the community level. However, in STH-infected 
subjects, anthelmintic treatment led to a significant increase in IR[29], providing 
the first evidence on the causal association between helminth infections and IR 
in humans (chapter 3), further strengthening the evidence for the helminth-
associated protective metabolic effects documented in cross-sectional studies[11-
15] and animal models[3-8]. 
Interestingly, infection intensity and number of helminth species seems also to 
play a role. The increase in IR after anthelmintic treatment was  higher in helminth-
infected subjects, as assessed by microscopy, in comparison to helminth-
infected subjects, as assessed by PCR, the later detecting less clinically relevant 
infections[34]. Moreover, subjects infected with multiple helminth species showed 
a more pronounced increase in IR after anthelminthic treatment, which suggests 
the importance of, not only infection intensity, as these subjects infected with 
multiple helminth species had a higher infection intensity in comparison to those 
infected with single species, but also the importance of polyparasitism for the 


















same population also support this notion, as increasing number of STH species was 
also associated with a progressively lower IR[14].
Following the evidence of a causal relation between helminth and IR, it would be 
important to be able to understand the pathways involved. Despite the significant 
reduction in Th2 responses, as assessed by serum total IgE level and eosinophil count, 
this pathway does not seem to play a role in the increased IR, in particular the total IgE. 
Although the presence of STH is an important determinant for total IgE level,[33] other 
environmental exposures or conditions can also affect total IgE. Our trial showed that 
the increased IR after anthelmintic treatment seems to be mainly mediated by the 
increased adiposity, as assessed by BMI, which is not surprising as adiposity has been 
closely associated with nutrition and the development of IR.[36] However, a role for 
eosinophils was shown when additional adjustment for eosinophil counts further 
attenuated the increased IR. This suggests that eosinophils, if anything, might be 
involved in the causal pathway. The possible role of eosinophils in affecting glucose 
homeostasis has been shown in animal models[3-6] and a human study[37].
Although our trial has shown that anthelmintic treatment increased adiposity, 
this only gives us limited information on the pathways involved in mediating the 
beneficial effects of helminths in humans. It is interesting to study whether the 
increase in adiposity is solely responsible for the increased IR, or it is also associated 
with changes in the physiology of AT. Studies in animal models of diet-induced 
obesity have shown that indeed chronic helminth infection is associated with less 
fat mass gain,[4] of which associated with increased white AT M2 macrophages 
and eosinophils, as well as less IR.[4] Interestingly, helminth-derived molecules 
also induce a similar type 2 responses and beneficial metabolic effects without any 
significant changes in body fat.[4, 5] 
In human, however, it was not possible to perform AT biopsies. We therefore 
assessed the effect of anthelmintic treatment on adipokines, mediators secreted 
by human AT, especially leptin and adiponectin, two major adipokines which have 
been shown to have pro and anti-inflammatory properties, respectively, as well as 
resistin, which has been reported to be increased in helminth infected subjects[38] 
(chapter 4).  Indeed, anthelmintic treatment in helminth-infected subjects 
increased the leptin to adiponectin ratio, and through mediation analysis we 
showed that this increase may be involved in the anthelmintic-associated increase 


















after anthelmintic treatment was mainly caused by the significant reduction in 
adiponectin level, an anti-inflammatory adipokine [39], and to a lesser extent, 
through an increase in leptin level, a pro-inflammatory adipokine [39]. No causal 
association between helminth infection and resistin, a pro-inflammatory adipokine, 
was observed in our trial, contrasting the previously reported finding.[38]
Furthermore, the increase in leptin level after anthelmintic treatment in STH-infected 
subjects might also suggest that STH suppresses leptin level, as levels recovered up 
to the levels in STH-uninfected subjects when STH were removed by anthelmintic 
treatment. Low leptin levels has been associated with higher susceptibility to 
infection[40-42] and lower autoimmunity.[43] Furthermore, as leptin can increase 
Th1 and suppress Th2 cytokine production,[40] and can act as a negative signal 
for the proliferation of human regulatory T cells [44], we may speculate that the 
supressed leptin level in helminth-infected subjects might contribute to helminth-
associated induction of modified type 2 and regulatory immune responses,[21] and if 
anything, contribute to a reduced helminth clearance from the host.[45] 
Next, as available evidence suggests that living in rural areas might provide relative 
protection against the development of T2D, in comparison to living in urban areas, 
we designed a study to compare the metabolic profile and responses to a short-
term HFD intervention between individuals with similar genetic background living 
in rural and urban areas. chapter 5 describes that subjects living in the urban area 
have a significantly lower STH infections, as well as lower total IgE levels. These 
subjects had higher whole-body IR, which was mainly mediated by higher adiposity 
and leptin level. Past or current exposure to STH, as assessed by total IgE, albeit 
small, contributed to the differences in whole-body IR, adiposity, and leptin level. 
However, neither rural living nor current STH infections protected against acute 
induction of IR by high-fat diet intervention. Thus, living in rural area, as well as 
having helminth infections, might only give a relatively weak protection against the 
strong induction of IR by short-term HFD, independent of the effect on adiposity. 
However, it is important to note that HFD did induce increased liver inflammation, 
as assessed by CETP level,[46-49] in individuals living in urban, but not in rural 
areas. The lack of increase in CETP level in rural subjects might be related to the 
fact that, in these subjects, the CETP levels were already high, thus precluding any 
further increase. Environmental factors in rural area may explain this high CETP 





























































































































also contribute.[50] However, the currently available data shows inconsistent 
results of the effect of different infection or inflammatory exposures on CETP 
level,[50, 51] thus further studies are needed to assess this. Next, as CETP also play 
a role in lipoprotein metabolism[47, 52-54], the questions whether this high CETP 
level in rural will also affect lipoprotein metabolism and subsequent development 
of atherosclerosis remains.
Our data, from the RCT and from the HFD study, have shown that adiposity seems 
to play a central role in the development of IR, as well as in mediating the helminth-
associated beneficial effects. Helminth parasites, through affecting food intake or 
absorption, could indeed influence adiposity and thereby IR. Taken together, a 
simplified schematic overview on the contribution of helminth infections on the 


















dirEcTions for fUTUrE rEsEarcH
controlled Human infections
Experimental infections with helminths or helminth-derived molecules in diet-
induced obese mice have shown to improve glucose tolerance and increase 
insulin sensitivity compared to controls [4-7]. Importantly, these experimental 
studies enable us to investigate the potential mechanisms by which helminths 
can influence metabolic outcomes. Therefore, controlled human infection (CHI) 
models will be an excellent approach to unravel the mechanism by which helminth 
infections can improve metabolic profiles in human. 
Human fat Biopsies
It is important to note that, in helminth-infected subjects, anthelmintic-associated 
increased IR seems to be mainly mediated by the increase in adiposity, as well as 
an increase in leptin to adiponectin ratio. Moreover, the difference in IR between 
subjects living in urban and rural areas is also mainly mediated by the difference in 
adiposity. Thus, assessments of human adipose tissue biopsies[55-57] could give a 
powerful grip on the underlying mechanism that mediate the effect of helminths 
and urbanization on the development of IR. 
gut microbiome
Intestinal helminths and bacteria reside in the same niche, the human intestine, and 
might interact with each other and affect the host immune system, nutrition, and 
metabolism.[58] Interestingly, emerging evidence suggests that the composition 
of gut microbiota plays a role in the pathogenesis of obesity-associated insulin 
resistance by affecting energy homeostasis and inflammation [59]. Therefore, 
alteration of the gut microbiome in the presence of helminth parasites,[60] might 
contribute to the observed difference in IR. Interestingly, whereas less bacterial 
diversity was commonly observed among obese people or diabetics [59, 61], 
greater bacterial diversity was recently reported among subjects infected with 
Schistosoma haematobium [62] and STHs [63]. However, the findings on the effects 
of STH infections on gut microbiota has not been consistent, as some studies 
showed them to be associated with a reduced bacterial diversity[64]. 
The effect of deworming on gut microbiota has also been inconsistent, whereas 
two studies reported no changes in gut microbiota composition[62, 64], one 
study reported alteration in gut microbiota composition, most notably, reduced 


















hookworm infection failed to induce changes in bacterial diversity, however it did 
induce a minor increase in the richness of the microbial species [66]. Interestingly, 
in mice, helminth infections are associated with an increase of intestinal short chain 
fatty acids (SCFA) [67], the end products of dietary carbohydrate fermentation, 
which has been shown to play an important role in the control of body weight and 
insulin sensitivity [68]. 
Taken together, helminth-associated diversity of the gut microbiome and amount 
of SCFAs might mediate the effects of helminths on whole-body IR. However, 
further studies are needed to confirm these findings, and unravel the complex 
interaction between helminth infections, gut microbiome, the host immune 
system and metabolism. 
rural to urban study
With the increasing burden of NCDs, which are mostly reflect the increasing rate 
of urbanization, additional efforts should be invested in assessing urbanization-
associated changes in metabolic homeostasis, immune responses, and 
inflammation. Specific focus  should be put into urbanization-associated decreased 
biodiversity, which might be potentially related to the emergence of inflammatory 
diseases,[16] including T2D. This is supported by two studies showing different 
immune activation profiles between subjects living in rural and urban areas,[69, 70] 
which suggests that environmental differences may contribute to immunological 
footprints, thus affecting the development of inflammatory diseases. However, 
the contribution of these differences in the immune system to the development of 
IR, hence T2D, remain to be clarified.
dirEcTions for fUTUrE HEalTH policY and carE
In terms of health policy, control measures for communicable diseases, such 
as elimination of STH, need to go hand in hand with providing education, 
prevention, and monitoring the development of major NCDs, especially obesity 
and T2D. More attention to urbanization-related changes in metabolic health, 
which is currently lacking, is needed. In terms of health care, it is important to 
develop locally or nationally practical and sensitive diagnostic tools to detect 
the presence of NCDs, such as T2D, applicable to many resource-limited rural 
areas of Indonesia. This, hopefully, will enable us to monitor the development of 
obesity and T2D, as well as enabling us to reduce the high number of undiagnosed 
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In the past few decades, there has been a substantial increase in the number 
of people with type 2 diabetes (T2D) worldwide, especially in low and middle 
income countries. In these countries, rapid socioeconomic developments and 
urbanization have led to changes in diet, lifestyle, and environmental factors. This 
in turn is associated with complex changes in disease pattern, evident from the 
increasing prevalence of non-communicable diseases, including T2D, as well as 
the reduction in communicable diseases. Despite the strong evidence that T2D 
is associated with increased risk of infectious diseases, and that the presence of 
infections will worsen the host glucose metabolism, recent evidence suggests 
that helminth infections might give protection against the development of T2D. In 
this thesis, we reported our investigations on the impact of helminth infections, in 
light of increasing urbanization, on the development of T2D in Indonesia.
chapter 1
Here we discussed the increasing prevalence of non-communicable diseases, 
especially T2D, in Indonesia, which is largely attributed to the rapid pace of 
socioeconomic development and urbanization.  As a result, there is great 
geographical variation where high prevalence of T2D is seen in urban areas but 
low prevalence in rural regions of the country. This might suggest that traditional 
living environments in rural areas might give a relative protection against the 
development of T2D. This protection against the development of T2D has been 
reported to be mainly related to the more physically active lifestyle and healthier 
traditional diet, however other environmental factors might play a role as well. 
Several epidemiological studies, conducted in different populations, suggest 
that helminth infections, which are still endemic in many rural areas of low and 
middle income countries, including Indonesia, might confer protection against 
the development of T2D. 
chapter 2
Here we described in detail our study protocol to investigate whether helminth 
infections have a direct effect on insulin resistance, a marker and strong predictor 
for the development of T2D. To achieve this, we designed a large-scale randomised 
population-based, household-clustered, double-blind placebo-controlled trial of 
anthelmintic treatment in an area endemic for soil-transmitted helminth (STH), on 
Flores Island, Indonesia. The 12-months anthelmintic treatment regimen consisted 
of four rounds of three monthly 400mg albendazole or matching placebo given 
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for three consecutive days under direct supervision. We performed clinical 
anthropometry measurements, as well blood, urine, and stool sample collections 
before and after the anthelmintic treatment to assess any changes in insulin 
resistance (and other metabolic parameters), as well as immune responses, after 
reduction in STH infection prevalence and intensity.
chapter 3 
This chapter reported the main outcomes of an intensive 12-months anthelmintic 
treatment. Our intensive treatment significantly reduced STH prevalence and 
intensity, but did not eliminate these infections. Importantly, anthelmintic 
treatment in helminth-infected subjects lead to a significant but slight increase in 
insulin resistance, providing the first causal evidence on the protective effect of 
helminths on insulin resistance, hence T2D. Furthermore, the increase in insulin 
resistance was mainly mediated by the increase in body mass index, suggesting 
the importance of human adipose tissue in helminth-associated beneficial 
metabolic effects. 
chapter 4
Here we provided additional evidence on the importance of human adipose tissue 
in helminth-associated beneficial metabolic effects. Anthelmintic treatment in 
helminth-infected subjects lead to significant changes in two hormones secreted 
by adipose tissue, namely leptin and adiponectin. We observed an increase in leptin 
to adiponectin ratio which may contribute to the increase in insulin resistance. 
While leptin has been associated with inflammation and insulin resistance, 
the converse has been reported for adiponectin.  Thus, leptin to adiponectin 
ratio can be regarded as a marker of a balance between inflammation and anti-
inflammation, and has, in some studies,  been reported to be positively associated 
with insulin resistance.
chapter 5
In order to assess the contribution of different living environments on the 
development of T2D, we compared the metabolic profiles between people living 
in rural and urban area with similar genetic background. People who moved from 
Flores island to Jakarta had a higher degree of insulin resistance, which was mainly 
due to the higher adipose tissue mass and leptin level. Increasing time spent in 
urban area was positively associated with higher adipose tissue mass. Next, to 
assess whether rural living environments protect against diet-induced insulin 
resistance, we compared the metabolic response on a high-fat high-calorie diet 
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(HFD) between rural and urban participants with the same amount of adipose 
tissue mass. Living in a rural area or having current helminth infection, did not 
protect against the induction of insulin resistance by short term HFD intervention. 
chapter 6
This chapter summarizes and discusses the main findings of this thesis. First, we 
have proven that helminth infections do have a causal effect on the development 
of insulin resistance. Thus, the currently on going deworming programs 
might accelerate the development of T2D, which advocates that the current 
deworming program should go hand in hand with efforts to monitor and prevent 
the development of obesity and T2D. Second, the effect of helminths on the 
development of T2D seems to be mainly explained by reduction of adipose tissue 
mass, as well as modulating secretion of adiponectin and leptin. Third, living in 
urban area is also associated with higher insulin resistance, hence a higher risk to 
develop T2D, which is mainly explained by a progressive increase in adipose tissue 
mass with increasing duration of time spent in an urban area. In addition, although 
it is not a major question in our study, the findings in our deworming trial suggests 
that the current World Health Organization deworming treatment regimen might 




In de laatste decennia is het aantal mensen met type 2 diabetes (T2D) wereldwijd 
toegenomen, met name in landen met een laag of gemiddeld inkomensniveau. 
In deze landen hebben snelle sociaal economische ontwikkelingen en urbanisatie 
geleid tot veranderingen in dieet, leefstijl en omgevingsfactoren. Dit gaat gepaard 
met veranderingen in ziekte patronen, zoals blijkt uit de toenemende prevalentie 
van niet-overdraagbare ziekten zoals T2D, en tegelijkertijd een afnemende 
prevalentie van overdraagbare ziekten. Hoewel T2D wordt geassocieerd met een 
vergroot risico op infectieziekten, waarbij de aanwezigheid van infecties het glucose 
metabolisme van de patiënt verslechtert, hebben recente studies aangetoond dat 
worminfecties mogelijk bescherming bieden tegen de ontwikkeling van T2D. In 
dit proefschrift wordt het effect van worminfecties op de ontwikkeling van T2D in 
Indonesië beschreven in de context van toenemende urbanisatie. 
Hoofdstuk 1
In dit hoofdstuk wordt de toenemende prevalentie van niet-overdraagbare ziekten, 
met name T2D, in Indonesië beschreven. Deze toename wordt grotendeels 
toegeschreven aan snelle sociaal economische ontwikkelingen en urbanisatie, 
veranderingen die leiden tot grote geografische variatie waarbij de prevalentie van 
T2D in stedelijke gebieden hoog en in de landelijke gebieden laag is. Dit zou erop 
kunnen wijzen dat de traditionele leefomgeving in landelijke gebieden wellicht 
bescherming biedt tegen de ontwikkeling van T2D. Hoewel deze bescherming 
met name toe te wijzen is aan de verschillen in leefstijl en dieet, kunnen andere 
omgevingsfactoren zoals worminfecties ook een rol spelen. Worminfecties 
komen veel voor in landelijke gebieden van landen met een laag of gemiddeld 
inkomensniveau zoals Indonesië, en een aantal epidemiologische studies heeft 
in verschillende populaties aangetoond dat worminfecties wellicht bescherming 
bieden tegen de ontwikkeling van T2D. 
Hoofdstuk 2
Hier beschrijven we het studieprotocol dat is gebruikt om te onderzoeken of 
worminfecties een direct effect hebben op insuline resistentie, een indicator en 
voorspeller voor de ontwikkeling van T2D. Deze studie vond plaats op Flores, een 
eiland in Indonesië, waar veel mensen besmet zijn met wormen in het maag-darm 
kanaal. Gedurende één jaar is de helft van de onderzoeksgroep behandeld tegen 
worminfecties en de andere helft met een placebo. Deelnemers ontvingen hiervoor 
elke drie maanden, drie dagen achter elkaar medicatie tegen worminfecties of een 
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placebo. Naast het uitvoeren van antropometrische metingen (lengte, gewicht, 
heup- en tailleomvang), zijn er voor en na de behandeling bloed, urine en feces 
monsters verzameld om veranderingen in insuline resistentie (en andere metabole 
parameters) en de immuunrespons te kunnen meten. 
Hoofdstuk 3
Dit hoofdstuk beschrijft de uitkomsten van de studie beschreven in hoofdstuk 2. 
Hoewel de behandeling tegen wormen er toe heeft geleid dat de prevalentie en 
intensiteit van worminfecties na één jaar sterk verlaagd was, waren er nog steeds 
enkele mensen besmet met wormen. Toen we het effect van de behandeling 
op insuline resistentie onderzochten, bleek dat er een kleine, maar significante 
toename in insuline resistentie was opgetreden in de groep mensen die voor 
aanvang van de behandeling geïnfecteerd waren. Dit is het eerste directe bewijs 
waaruit blijkt dat worminfecties een beschermend effect hebben op insuline 
resistentie, en dus de ontwikkeling van T2D. Daarnaast bleek dat de toename in 
insuline resistentie vooral was toe te wijzen aan een toename in Body Mass Index 
(BMI). Het lijkt er dus op dat het vetweefsel een belangrijke rol speelt in het 
gunstige effect dat worminfecties hebben op het glucose metabolisme. 
Hoofdstuk 4
We hebben nader onderzocht hoe het vetweefsel betrokken is bij het gunstige 
effect van worminfecties op het glucose metabolisme, door te kijken naar het 
effect van anti-wormen behandeling op twee hormonen die worden uitgescheiden 
door het vetweefsel, namelijk leptine en adiponectine. Terwijl leptine wordt 
geassocieerd met inflammatie en insuline resistentie,  geldt het tegenovergestelde 
voor adiponectine. Daarom kan de ratio  tussen leptine en adiponectine 
worden beschouwd als een marker voor ontsteking, en eerdere studies hebben 
aangetoond dat deze ratio positief geassocieerd is met insuline resistentie. Na één 
jaar behandeling tegen wormeninfecties zagen we een toename in de ratio tussen 
leptine en adiponectine in de groep mensen die voorafgaand aan de behandeling 
geïnfecteerd waren, en dit zou kunnen bijdragen aan de eerder beschreven 
toename in insuline resistentie. 
Hoofdstuk 5
Om te onderzoeken in hoeverre de leefomgeving bijdraagt aan de ontwikkeling 
van T2D, hebben we het metabole profiel vergeleken tussen mensen die in 
een landelijk (Flores) versus stedelijk (Jakarta) gebied van Indonesië wonen. De 
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genetische achtergrond van deze mensen was hetzelfde aangezien de mensen 
in het stedelijke gebied oorspronkelijk uit Flores kwamen. Het bleek dat de mate 
van insuline resistentie in de groep mensen in het stedelijke gebied hoger was 
in vergelijking met mensen in het landelijke gebied. Dit was voornamelijk toe te 
wijzen aan een hogere vetweefsel massa en een hoger leptine niveau. We zagen 
dat de tijdsduur die men in de stad had doorgebracht positief geassocieerd was 
met een hogere vetweefsel massa. 
We hebben ook onderzocht of een landelijke leefomgeving bescherming biedt 
tegen een toename in insuline resistentie die veroorzaakt wordt door een dieet 
met veel vet en calorieën. Hiervoor zijn de metabole parameters in reactie op 
dit dieet gemeten in mensen die in een landelijk versus stedelijk gebied wonen, 
waarbij de deelnemers een vergelijkbare hoeveelheid vetweefsel hadden. De 
landelijke leefomgeving, inclusief de blootstelling aan wormeninfecties, bood 
geen bescherming tegen de toename in insuline resistentie die het kortdurende 
dieet veroorzaakte. 
Hoofdstuk 6
In dit hoofdstuk worden de belangrijkste bevindingen van dit proefschrift 
samengevat en bediscussieerd. We hebben aangetoond dat worminfecties een 
direct effect hebben op de ontwikkeling van insuline resistentie. Dit betekent dat 
de huidige behandelprogramma’s tegen worminfecties de ontwikkeling van T2D 
wellicht versnellen, en om die reden zou het goed zijn als er tegelijkertijd ook 
aandacht wordt besteed aan het monitoren en voorkomen van de ontwikkeling 
van obesitas en T2D. Daarnaast is gebleken dat het effect van worminfecties op 
de ontwikkeling van T2D grotendeels kan worden verklaard door een afname in 
vetweefsel massa en een verandering in de uitscheiding van adiponectine en leptine. 
Tot slot hebben we gezien dat het wonen in een stedelijk gebied geassocieerd 
is met een hogere mate van insuline resistentie, en dus een groter risico op de 
ontwikkeling van T2D. Dit is toe te wijzen aan een sterke toename in vetweefsel 
massa, gerelateerd aan de tijdsduur die een persoon in de stad heeft doorgebracht. 
Hoewel het niet de hoofdvraag van onze studie was, tonen de bevindingen in deze 
studie waarbij mensen één jaar lang behandeld zijn tegen worminfecties aan dat 
de huidige behandelprogramma’s van de Wereldgezondheidsorganisatie (WHO) 
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